The effect of prenatal marijuana exposure on offspring marijuana use and cannabis use disorder in young adulthood by Sonon, Kristen
 THE EFFECT OF PRENATAL MARIJUANA EXPOSURE ON OFFSPRING 
MARIJUANA USE AND CANNABIS USE DISORDER IN YOUNG ADULTHOOD 
 
 
 
 
 
 
 
 
by 
Kristen Elisabeth Sonon 
BS, Pennsylvania State University, 2003 
MHA, University of Pittsburgh, 2005 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of the 
Graduate School of Public Health in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2013 
 
 ii 
UNIVERSITY OF PITTSBURGH 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Kristen Elisabeth Sonon 
 
 
 
It was defended on 
November 11, 2013 
and approved by 
Jack R. Cornelius, MD, Professor, Department of Psychiatry, School of Medicine, University 
of Pittsburgh  
 
Kevin H. Kim, PhD, Associate Professor, Department of Psychology in Education, School of 
Education, University of Pittsburgh  
 
Gale A. Richardson, PhD, Associate Professor, Departments of Psychiatry and Epidemiology, 
School of Medicine and Graduate School of Public Health, University of Pittsburgh  
 
Dissertation Advisor:  Nancy L. Day, PhD, Professor, Departments of Psychiatry and 
Epidemiology, School of Medicine and Graduate School of Public Health,  
University of Pittsburgh 
 
 
 iii 
Copyright © by Kristen Elisabeth Sonon 
2013 
 iv 
  
Marijuana is the most commonly-used illicit substance among pregnant women. Few 
studies have been conducted on the long-term effects of prenatal marijuana exposure (PME) on 
offspring. This dissertation examines the association between PME and offspring marijuana use 
and cannabis use disorder (CUD) in young adulthood.  
 First, the association between PME and offspring frequency of marijuana use at 22 years 
of age was evaluated. PME was defined as a continuous measure of the average daily joints and 
frequency of use by the offspring was defined as no use, using less than three times per week, 
and using three times per week or more. An ordinal logistic regression model was used. Results 
showed that PME was initially significant but this association was attenuated to non-significance 
after adjusting for covariates. Childhood maltreatment, but not race or gender, moderated the 
association between PME and offspring use. PME was associated with offspring frequency of 
use at low levels of childhood maltreatment, but not at high levels of childhood maltreatment. 
Second, a path analysis was used to evaluate pathways from PME to frequency of 
marijuana use in offspring. Results showed a significant indirect path through early initiation of 
marijuana. There was also a significant indirect path through depressive symptoms and early 
initiation of marijuana. In addition, PME predicted early marijuana initiation but maternal 
marijuana use during the offspring’s childhood did not.  
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Third, a path analysis was used to evaluate pathways from PME to CUD. Results showed 
a significant indirect path of PME on CUD through early initiation of marijuana. There was also 
a significant indirect path of PME on CUD through depressive symptoms in childhood and early 
initiation of marijuana.  
In summary, PME may create a biologic vulnerability in offspring. In addition, aspects of 
the offspring’s environment also contribute to marijuana use and CUD in young adulthood. The 
findings of this dissertation are significant to public health. Healthcare professionals should 
encourage pregnant women to abstain from marijuana and public health programs should target 
youth to delay marijuana initiation.   
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1.0  INTRODUCTION 
1.1 OVERVIEW OF CANNABIS AND ITS EFFECTS ON DEVELOPMENT 
1.1.1 Cannabis and its consumption 
Cannabis is an illicit substance made from the Cannabis sativa plant (Leung, 2011). There are 
several types of preparations, with most derived from the female plant (Hall & Solowij, 1998). 
The herbal form, marijuana, is a dried mixture of the stems, seeds, leaves, and flowers of the 
plant (National Institute on Drug Abuse [NIDA], 2012b). Hashish or hash is a resin created from 
pressing the resin glands from unfertilized buds of the plant (United Nations Office on Drugs and 
Crime [UNODC], 2012). Finally, cannabis and hash oils are the concentrated extract of the plant 
in liquid or semi-liquid form (Mehmedic et al., 2010; UNODC, 2012).  
Cannabis is most commonly smoked in a cigarette, pipe, or blunt (Hazekamp, Bastola, 
Rashidi, Bender, & Verpoorte, 2007; NIDA, 2012b). It can also be consumed by inhaling a 
vaporized preparation, drinking it as a brewed tea, or eating it in prepared food (Hazekamp et al., 
2007; NIDA, 2012b). 
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1.1.2 Prevalence of cannabis use 
Cannabis is the most commonly used illicit substance in the world (UNODC, 2012). Annual 
prevalence estimates from the World Health Organization (WHO) demonstrate that among those 
15-64 years of age there are between 119-224 million cannabis users, representing 2.5%-5% of 
the world’s population (UNODC, 2012). In the US, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) collects annual prevalence estimates about cannabis use 
through the National Survey on Drug Use and Health (NSDUH). In 2011, approximately 
18.1 million people, or 7% of the US population ages 12 years and older, reported using 
marijuana in the past month (Substance Abuse and Mental Health Services Administration 
[SAMHSA], 2012a).  
1.1.3 Definition and prevalence of Cannabis Use Disorder 
Cannabis Use Disorder (CUD) is defined using criteria from the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) (WHO, 2012; 
American Psychiatric Association [APA], 2000). The DSM-IV-TR makes a distinction between 
substance abuse and dependence and these definitions are mutually exclusive (Appendix, Table 
9). To be diagnosed with abuse, individuals must have experienced at least one of the criteria 
from the DSM-IV-TR within the past 12 months, and they cannot have met the criteria for 
dependence in the past (APA, 2000). To be diagnosed with dependence, individuals must have 
experienced at least three of the criteria from the DSM-IV-TR within the past 12 months (APA, 
2000).  
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US national surveys provide estimates about the prevalence of CUD. The National 
Epidemiologic Survey on Alcohol and Related Conditions (NESARC) conducted from 2001-
2002 demonstrated that the past-year prevalence of CUD was 1.5%, with 1.1% experiencing 
abuse and 0.4% experiencing dependence (Stinson, Ruan, Pickering, & Grant, 2006). The 
National Survey on Drug Use and Health (NSDUH) provides a past-year CUD estimate that 
combines abuse and dependence. For nearly a decade, CUD rates have remained relatively 
stable. The past-year prevalence rate in 2012 was 1.7%, representing 4.3 million people 
(SAMHSA, 2013).  
Survey findings on lifetime history of CUD are sparse. The National Comorbidity Survey 
conducted from 1990-1992 demonstrated that 4.2% had a lifetime diagnosis of cannabis 
dependence (Anthony, Warner, & Kessler, 1994). Ten years later, the NESARC data 
demonstrated that 8.5% had lifetime CUD, with 7.2% experiencing abuse and 1.3% experiencing 
dependence (Stinson, Ruan, Pickering, & Grant, 2006).  
1.2 FACTORS ASSOCIATED WITH CANNABIS USE AND CANNABIS USE 
DISORDER 
Many factors are associated with cannabis initiation, use, and CUD. This section summarizes 
demographic and risks factors identified in the literature. 
 4 
1.2.1 Demographic factors 
Age, gender, socioeconomic status (SES), and race are used to describe individuals who initiate 
and continue to use marijuana and have a CUD diagnosis. According to the 2012 NSDUH 
findings, the average age of first use among recent initiates ages 12-49 was 17.9 years 
(SAMHSA, 2013). This age of marijuana initiation has remained relatively stable over the past 
ten years (SAMSHA, 2013). Marijuana use is highest between ages 15-30 and use declines after 
that time (Sundram, 2006). Age of initiation is a risk factor for cannabis dependence (Chen, 
O'Brien, & Anthony, 2005). Those who initiate cannabis at an early age are more likely to be 
diagnosed with a CUD later in life. Additionally, CUD onset is more likely to occur among 
individuals less than 30 years of age (Stinson, Ruan, Pickering, & Grant, 2006). 
The literature offers conflicting evidence about gender differences in marijuana initiation. 
Some studies report that males initiate earlier and others report no significant difference between 
the sexes (Day, Goldschmidt, & Thomas, 2006; D. B. Kandel & Chen, 2000; Korhonen et al., 
2008; Porath & Fried, 2005; Richardson, Larkby, Goldschmidt & Day, 2013). Marijuana use 
estimates are higher for men compared to women. Recent findings from the NSDUH indicate 
that among persons aged 12-17, the percentage of users is higher for males compared to females 
but the gap is narrowing (SAMSHA, 2013). Both the US National Longitudinal Alcohol 
Epidemiologic Survey (NLAES) conducted from 1991-1992 and NESARC surveys indicate a 
difference in sex with males having higher rates of CUDs than women. The estimates for abuse 
were 1.9% for males and 0.6% for females in the NLAES, and 2.2% for males and 0.8% for 
females in the NESARC (Compton et al., 2004). Further, male gender was a significant predictor 
of use and CUD in longitudinal studies (Hayatbakhsh, Najman, Bor, O'Callaghan, & Williams, 
2009; Perkonigg et al., 2008; von Sydow et al., 2001). 
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Studies evaluating socioeconomic status (SES) as a predictor of marijuana initiation, use, 
and CUD also offer conflicting results. In a recent review article, Hanson and Chen (2007) 
evaluated 25 studies of Western samples of youth and concluded that SES was not related to use 
during adolescence. Chen and colleagues (2005) and Stinson and colleagues (2006) found that 
low SES was associated with CUD when analyzing data from US populations. However, authors 
evaluating data from an Australian birth cohort concluded that SES in adolescence was not 
associated with use and CUD in young adulthood (Hayatbakhsh et al., 2009).  
Race was not identified as a significant predictor of marijuana initiation in two US birth 
cohorts (Day et al., 2006; Richardson et al., 2013). However, racial and ethnic differences have 
been reported with marijuana use. In an analysis of the Monitoring the Future (MTF) data, a  
study of middle and high school student use, Wallace and colleagues (2003) found use was 
highest among Native Americans, followed by Hispanics, whites, and blacks. Use was lowest 
among Asian-Americans. Racial and ethnic differences associated with CUD have been 
changing. Results from the NLAES conducted from 1991-1992 showed that whites had the 
highest prevalence of CUD, followed by blacks, and then Hispanics at 0.6% (Compton et al., 
2004). In the US National Household Survey on Drug Abuse conducted in 2000-2001, Chen and 
colleagues (2005) concluded there were no differences by race. Findings from the NESARC 
indicate that blacks had the highest prevalence of CUD, followed by whites, and then Hispanics 
(Compton et al., 2004). Most recently, analyses of survey data from the NSDUH also suggest 
that CUD is more common among African-Americans (Pacek, Malcolm, & Martins, 2012). 
Therefore, surveys from the past several years indicated that CUD diagnosis among minority 
populations is on the rise.  
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1.2.2 Risk factors  
Numerous risk factors for marijuana initiation, use, and CUD have been identified in cross-
sectional and longitudinal studies. Here we have categorized findings according to psychosocial 
factors, influences from the home environment, the influence of peers, the use of licit and illicit 
substances, genetics and family history, and prenatal substance exposure.  
Psychosocial characteristics are associated with marijuana initiation, use, and CUD.  
Predictors of initiation include antisocial behavior, depressive symptoms, and aggression in 
childhood, as well as having low school aspirations (Coffey, Lynskey, Wolfe, & Patton, 2000; 
Miller & Miller, 1997; Day et al., 2006; Hayatbakhsh et al., 2008). Factors associated with use 
included having antisocial personality diagnosis, low self-competence, distressing life events, a 
history of sexual abuse, having a high number of symptoms of depression and anxiety, 
aggressive and delinquent behavior, and breaking rules at school (Hayatbakhsh et al., 2009; 
Perkonigg et al., 2008). Factors associated with CUD included a history of sexual abuse, self-
reported below-average school performance, aggressive and delinquent behavior, breaking rules 
at school, having frequent arguments with a partner, psychological symptoms, having violence 
directed toward the individual, and expressing violence toward others (Brook, Lee, Finch, 
Koppel, & Brook, 2011; Hayatbakhsh et al., 2009). 
Parental supervision and control predicted marijuana initiation in adolescence 
(Hayatbakhsh et al., 2008; Richardson et al., 2013). Being born to a teenage mother was also 
identified as a risk factor (Hayatbakhsh et al., 2008). Factors associated with marijuana use 
include leaving the family home before the age of 18, family conflict, change in mother’s marital 
status, and maternal smoking when the offspring was an adolescent (Day et al., 2006; 
Hayatbakhsh et al., 2008; Hayatbakhsh et al., 2009; von Sydow, Lieb, Pfister, Hofler, & 
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Wittchen, 2002). Further, maternal use of marijuana when the offspring were adolescents 
predicted frequency of offspring marijuana use (Day et al., 2006). In addition to the change in 
mother’s marital status and maternal smoking when the offspring was an adolescent, parental 
death before the age of 15 is a risk factor for cannabis dependence (Hayatbakhsh et al., 2009; 
von Sydow et al., 2002). 
Cannabis use school-wide and peer use are predictors of marijuana initiation (Coffey et 
al., 2000; Miller & Miller, 1997). Individuals who report that they have more than one peer who 
used marijuana are more likely to use marijuana (Perkonigg et al., 2008). Individuals with a 
CUD are more likely to report associating with peers who display deviant behavior and peers 
who used drugs (Brook et al., 2011). 
Historically, the initiation of tobacco and alcohol has been shown to occur before the 
initiation of marijuana (D. Kandel & Faust, 1975). Recent studies on adolescents and adults have 
supported that the use of other substances often precedes marijuana initiation. For example, 
alcohol consumption and daily cigarette smoking predict marijuana initiation (Coffey et al., 
2000). Smoking cigarettes and alcohol use by age 14 are predictors of marijuana use and CUD 
(Hayatbakhsh et al., 2009). Finally, the use of other illicit substances has been shown to 
significantly predict cannabis dependence (von Sydow et al., 2002). 
A family history of drug and alcohol problems is associated with marijuana initiation 
(Day et al., 2006; Richardson et al., 2013). Parental history of substance use and problematic 
substance use are associated with marijuana use (von Sydow et al., 2002). Self-reported family 
history measures are often seen in the literature because published findings on genetic influences 
are limited. The heritability is between 0.13 and 0.72 for cannabis initiation (Vink, Wolters, 
Neale, & Boomsma, 2010), between 0.17 to 0.67 for cannabis use, and between 0.45 to 0.78 for 
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CUD (Agrawal & Lynskey, 2006). Considering the wide range of these heritability estimates, 
additional research is needed to clarify genetic and environmental influences. 
Finally, few studies have published findings on prenatal exposures as predictors of 
offspring cannabis initiation, use, and CUD. Prenatal marijuana exposure (PME) predicted 
offspring initiation of marijuana and frequency of marijuana use in adolescent offspring (Day et 
al., 2006; Porath & Fried, 2005). Prenatal exposure to tobacco also predicted offspring initiation 
of marijuana in two US birth cohorts (Day et al., 2006; Richardson et al., 2013). To date, there 
are no published findings on PME as a predictor of CUD. 
In summary, many factors are associated with marijuana initiation, use, and CUD. The 
variability of factors identified in the literature suggests that there are many pathways to 
substance use and disordered use that are important to evaluate in this dissertation. 
1.3 OVERVIEW OF THE ENDOGENOUS CANNABINOID SYSTEM 
There are nearly 60 cannabinoids in the Cannabis sativa plant (Gomez-Ruiz, Hernandez, de 
Miguel, & Ramos, 2007). The cannabinoid Delta-9-tetrahydrocannabinol (THC) is the main 
psychoactive ingredient in marijuana (National Institute on Drug Abuse, 2012c). When 
marijuana is consumed, THC enters the blood stream and interacts with the endocannabinoid 
system (ECS).  
The ECS is a lipid signaling system located throughout the body (Rodriguez de Fonseca 
et al., 2005). This signaling system has several main roles:  stress response and recovery in 
which endocannabinoids return the body to a level of homeostasis by working through the 
endocrine and nervous systems; control of energy by regulating food intake and how it is used in 
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the body; immune regulation and inflammatory responses; and reproduction (Castillo, Younts, 
Chavez, & Hashimotodani, 2012; Fride, 2004; Hillard, Weinlander, & Stuhr, 2012; Tasker, 
2004). Here we describe two main components of the ECS:  endocannabinoids and cannabinoid 
receptors (Fride, 2008; Gomez-Ruiz et al., 2007). 
To date, five endocannabinoids or endogenous ligands have been identified as part of the 
ECS. These are: arachidonoyl ethanol amide (anandamide or AEA), 2-arachidonoyl glycerol (2-
AG), noladin ether (2-arachidonyl glycerol ether), arachidonoyl dopamine (NADA), and 
virodhamine (Gomez-Ruiz et al., 2007; Jutras-Aswad, DiNieri, Harkany, & Hurd, 2009).  
AEA and 2-AG were the first endocannabinoids identified and have been studied in 
greater detail than the others (Fride, 2002; Gomez-Ruiz et al., 2007). They are produced by the 
body and released on demand, but the mechanism for how this is done is not fully understood 
(Pazos, Nunez, Benito, Tolon, & Romero, 2005). AEA release is initiated by rises in Ca2+ 
(calcium ion) or by the activation of neurotransmitter receptors, specifically dopamine (Freund, 
Katona, & Piomelli, 2003).  
When endocannabinoids are released, they activate the cannabinoid receptors. To date, 
two cannabinoid receptors have been identified: CB1 and CB2 (Jutras-Aswad et al., 2009). CB1 
receptors are present in the reproductive, immune, and digestive systems and are abundant in the 
brain (Fride, 2004; Jutras-Aswad et al., 2009). There is a high concentration of CB1 receptors in 
the hippocampus, basal ganglia, and cerebellum, which are associated with learning and forming 
memories, affect, and generating and controlling movement (Fride, 2002; Jutras-Aswad et al., 
2009; Strick, Dum, & Fiez, 2009; Sundram, 2006). There is a moderate concentration of CB1 
receptors in the cerebral cortex and nucleus accumbens, which are associated with cognition, 
attention, and reward and effort-based functions (Jutras-Aswad et al., 2009; Salamone, Correa, 
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Farrer, & Mingote, 2007; Sundram, 2006). Low concentrations of CB1 receptors are found in the 
hypothalamus and brain stem, which manage signals regarding homeostasis such as body 
temperature, blood pressure, sleep, and energy (Rolls, Schaich Borg, & de Lecea, 2010; 
Sundram, 2006; Suzuki, Jayasena, & Bloom, 2012). Although CB2 receptors are found in the 
brain, they are predominately located throughout other systems of the body (e.g., immune 
system) (Gomez-Ruiz et al., 2007).   
THC mimics the endogenous cannabinoids (Gomez-Ruiz et al., 2007). When cannabis is 
consumed, there is an overstimulation of the ECS, which can alter the strength and efficacy of 
synaptic activity in the brain (Malenka, 2002).  
1.4 CANNABIS AND THE DEVELOPING CENTRAL NERVOUS SYSTEM 
Exposure to cannabis has implications for human reproduction. THC is an agonist at the 
cannabinoid receptors CB1 and CB2 and can mimic the endogenous cannabinoids (Gomez-Ruiz 
et al., 2007). Animal models demonstrate that one-third of the THC in maternal plasma crosses 
the placenta (Sundram, 2006). Thus, a pregnant woman can expose her offspring to cannabis 
during gestation. The brain begins to develop shortly after fertilization and exogenous cannabis 
can affect the ECS, opioidergic, serotoninergic, and dopaminergic systems. 
1.4.1 Endogenous cannabinoid system 
Immediately following conception, the ECS is involved in progenitor cell migration and 
differentiation, neuronal migration, and development of axonal pathways (Gaffuri, Ladarre, & 
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Lenkei, 2012; Wu, Jew, & Lu, 2011). In the second trimester, the ECS is implicated in creating 
functional synapses (Gaffuri et al., 2012). Postmortem fetal samples have identified active 
cannabinoid receptors as early as 14, 19, and 33 weeks gestation (Biegon & Kerman, 2001; 
Glass, Dragunow, & Faull, 1997; Mato, Del Olmo, & Pazos, 2003). This demonstrates that very 
early in development, the ECS is implicated in making the appropriate cells for neuronal 
development, migrating neurons to the right places, and beginning to have synapses firing 
between neurons.  
Cannabis can also affect the CNS after the prenatal period. THC is excreted in breast 
milk, although no long-term studies have evaluated its effects (Djulus, Moretti & Koren, 2005). 
Further, youth who choose to use cannabis may put themselves at risk for CNS changes. The 
CNS continues to develop through adolescence into young adulthood, and ECS functionality 
changes (Lebel & Beaulieu, 2011; Malone, Hill, & Rubino, 2010). There is a spike in AEA in 
mid-adolescence in the nucleus accumbens and AEA increases in the prefrontal cortex during 
adolescence (Malone et al., 2010). During this time, 2-AG declines in the nucleus accumbens 
and prefrontal cortex (Malone et al., 2010). Other structural and functional CNS changes take 
place from birth through adolescence. Synapses continue to develop, CB1 receptors change in 
their distribution with increases in the frontal cortex, striatum, and hippocampus, and there is 
growth in the volume of brain structures such as the hippocampus and prefrontal cortex (Malone 
et al., 2010).  
1.4.2 Opioidergic system 
CB1 and opioid receptors are present in the same structures of the CNS; thus, an interaction 
between the cannabinoid and opioid systems may exist (Maldonado, Valverde, & Berrendero, 
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2006). Opioid receptors are present in the fetal brain by mid-gestation, and there is evidence that 
PME results in increased mu-opioid receptor expression in the amygdala (Jutras-Aswad et al., 
2009). Further, the interaction between the two systems is associated with the regulation of 
reward (Navarro et al., 2001). Thus, a disruption to these systems during fetal development may 
have implications for emotion regulation, memory, and addiction later in life.  
1.4.3 Serotoninergic system 
Animal studies demonstrate that exposure to THC in the prenatal period affects serotonergic 
transmission (Jutras-Aswad, 2009). The raphe nuclei are the main source of serotonin, and THC 
causes a decrease in serotonin levels in the raphe nuclei as well as the hippocampus (Jutras-
Aswad, 2009). Therefore, it is believed that this disruption of the normal development of the 
serotoninergic system may put offspring at risk for mood disorders (Jutras-Aswad, 2009). 
1.4.4 Dopaminergic system 
Prenatal exposure to THC can also alter the development of the dopaminergic system. THC used 
during fetal development can lead to a decrease in the neurotransmitter D2 mRNA levels in the 
amygdala (Jutras-Aswad et al., 2009). This also may affect emotion regulation and memory later 
in life. 
In summary, disruption of brain development and function can occur early in the prenatal 
period as a result of THC exposure. Because the CNS continues to develop through adolescence, 
insults from marijuana use during this time can also disrupt brain development and function. 
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Collectively, these insults can be functional abnormalities manifested as behavior problems as 
the offspring ages.   
1.5 THE EFFECTS OF PRENATAL CANNABIS EXPOSURE ON OFFSPRING 
1.5.1 Marijuana use during pregnancy 
Marijuana is commonly used during pregnancy. The National Pregnancy and Health Survey, 
conducted by NIDA in 1992-1993, sampled women who had live-born infants from the 48 
contiguous states. The findings were that 2.9% or 119,000 women used marijuana at some point 
during their pregnancies (NIDA, 1996). More recently, findings from the NSDUH from 2002-
2007 suggest a slightly higher prevalence of use. In this nationally representative sample, 
pregnant women ages 18-44 were asked about their marijuana use in the past month. About 4.6% 
reported use in the first trimester, 2.9% in the second trimester, and 1.4% in the third trimester 
(SAMHSA, 2009). However, because these data are only for women at least 18 years of age, 
these rates may be underestimates due to use in pregnant teens (SAMHSA, 2009). 
Pregnant women who use marijuana tend to be: non-white, lower SES, less educated, 
younger, single, and to use other substances such as alcohol (Behnke & Eyler, 1993). In the 
Maternal Health Practices and Child Development (MHPCD) cohort, women who smoked at 
least one joint per day were more likely to be African American, unmarried, and to drink more 
alcohol compared to nonusers (Chandler, Richardson, Gallagher, & Day, 1996).  
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1.5.2 Prenatal marijuana exposure and offspring birth outcomes 
Few studies have published findings on the effects of prenatal marijuana exposure on birth 
outcomes. In the MHPCD cohort, PME was not significantly associated with length of gestation, 
preterm birth, birth weight, head circumference, chest circumference, or small for gestational age 
status, or morphologic abnormalities (Day & Richardson, 1991). However, PME was 
significantly associated with shorter length at birth (Day & Richardson, 1991).  
In comparison, the Ottawa Prenatal Prospective Study (OPPS) found a reduced length of 
gestation of about one week among women who smoked 6 or more times per week (Fried, 
Watkinson, & Willan, 1984). There were no differences in PME and non-PME exposed neonates 
in regard to major physical anomalies (Fried, 1982). However, the OPPS study found anomalies 
of true ocular hypertelorism and severe epicanthus that were not seen in the MHPCD cohort (N. 
Day et al., 1992; O'Connell & Fried, 1984). 
More recently, the Generation R study, currently underway in the Netherlands, found that 
women who used cannabis throughout pregnancy were more likely to have a fetus with growth 
restriction, defined as a lower fetal weight and smaller head circumference measured by 
ultrasound, compared to the fetuses of women who did not use cannabis during pregnancy (El 
Marroun et al., 2009). At birth, infants born to nonusers had a higher birth weight than infants 
born to users (El Marroun et al., 2009). The authors did not observe a difference in gestational 
age (El Marroun et al., 2009).  
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1.5.3 Prenatal marijuana exposure and offspring behavior 
In the neonatal period, offspring in the OPPS cohort were assessed within 8 days of birth using 
the Brazelton Neonatal Behavioral Assessment Scale (BNBAS; Brazelton, 1973). Those 
offspring exposed to marijuana prenatally had more tremors and startles and poorer habituation 
to light (Fried, 1980; Fried & Makin, 1987). Offspring in the MHPCD cohort were assessed at 48 
hours after birth using the BNBAS but there was no relationship between PME and behavior 
(Richardson, Day, & Taylor, 1989). In addition, a subsample of 55 neonates in the MHPCD 
cohort completed an EEG sleep study. Offspring exposed to ≥1 joints per day displayed more 
body movements and spent less time in total quiet sleep and trace alternant quiet sleep than 
unexposed offspring (Scher et al., 1988). 
Offspring in the MHPCD cohort were evaluated at 8 and 18 months using the Bayley 
Scales of Infant Development (BSID; 1969). Richardson and colleagues (1995) concluded that at 
8 months, PME did not predict lower scores on the Psychomotor Development Index (PDI). 
Third trimester PME, however, predicted lower scores on the Mental Development Index (MDI). 
Offspring exposed to ≥1 joints per day during the third trimester had scores about 10 points 
lower compared to women who smoked less than this amount or none at all. At 18 months, PME 
did not predict scores on either the MDI or PDI. Exposed and unexposed offspring in the OPPS 
cohort did not have significantly different PDI or MDI scores at 12 or 24 months of age (Fried & 
Watkinson, 1988). 
Chandler and colleagues (1996) found that PME did not significantly predict deficits in 
gross motor skills at age 3 in the MHPCD cohort. However, PME predicted lower scores on the 
short-term memory and verbal reasoning scales of the Stanford-Binet Intelligence Scale in the 
MHPCD cohort (Thorndike, Hagen, & Sattler, 1986; Day et al., 1994). PME also affected sleep 
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at age 3 in this cohort. An EEG sleep study demonstrated that PME was associated with lower 
sleep efficiency (percent of recorded time spent asleep), more minutes awake after sleep onset, 
and more arousals after sleep onset (Dahl, Scher, Williamson, Robles, & Day, 1995). 
At age 4, the McCarthy Scales of Children’s Abilities (McCarthy, 1972) were 
administered to individuals in the OPPS cohort. Offspring exposed to ≥5 joints per week had 
lower verbal and memory scores (Fried & Watkinson, 1990). At 5-6 years, PME was not 
associated with any of the scales on the McCarthy Scales of Children’s Abilities (Fried et al., 
1992). Additionally, in the OPPS cohort, children with PME did not differ from unexposed 
children on language and cognition at ages 5 and 6 (Fried, O'Connell, & Watkinson, 1992). 
At age 6, offspring in the MHPCD cohort with PME had deficits in attention as evaluated 
by a Continuous Performance Test (CPT) (Leech, Richardson, Goldschmidt, & Day, 1999). 
Impulsivity and inattention were reported more often for those with PME (Leech et al., 1999). 
Similarly in the OPPS cohort, offspring of mothers who used ≥5 joints per week during 
pregnancy had deficits in sustained attention on a vigilance task compared to offspring exposed 
to less than that amount or not at all (Fried, Watkinson, & Gray, 1992).  In this paper, mothers 
who used ≥5 joints per week during pregnancy rated their 6-year-old offspring as more 
impulsive/hyperactive on the Conners’ Parent Questionnaire (Conners, 1989) compared to 
offspring exposed to less than that amount or not at all (Fried, Watkinson, & Gray, 1992).   
At age 10 in the MHPCD cohort, PME in the first and third trimesters significantly 
predicted depressive symptoms measured by the Children’s Depression Inventory (CDI; Kovacs, 
1992; Gray, Day, Leech, & Richardson, 2005). Offspring behavior was assessed using the 
Swanson, Noland, and Pelham (SNAP; Pelham & Bender, 1982) measure and PME significantly 
predicted symptoms of hyperactivity, impulsivity, and inattention (Goldschmidt, Day, & 
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Richardson, 2000). In this same paper, mothers and teachers evaluated offspring behavior using 
the Child Behavior Checklist (CBCL; Achenbach, 1991a) and the Teacher’s Report Form (TRF; 
Achenbach, 1991b), respectively. Offspring exposed to ≥1 joints per day in the first trimester had 
higher scores on the CBCL delinquency subscale compared to those exposed to less than that 
amount or not at all. Offspring exposed to ≥3 joints per week in the second and third trimesters 
had higher scores on the TRF delinquency subscale compared to those exposed to less than that 
amount or not at all. The association between PME and delinquency was mediated by inattention 
(Goldschmidt et al., 2000).   
Neuropsychological outcomes were evaluated in the MHPCD cohort at age 10. 
Richardson and colleagues (2002) concluded that offspring exposed to ≥1 joints per day in the 
first trimester had lower memory scores on the Wide Range Assessment of Memory and 
Learning (WRAML; Sheslow & Adams, 1990) than those exposed to <1 joint per day. Second 
trimester PME expressed as a continuous measure of the average daily joints used also predicted 
more errors of commission on a CPT suggesting impulsivity (Richardson et al., 2002). Academic 
achievement was also evaluated in the MHPCD cohort at age 10. Goldschmidt and colleagues 
(2004) determined that heavy PME (≥1 joints per day) in the first trimester predicted lower 
reading and spelling scores on the Wide Range Achievement Test-Revised (WRAT-R; Jastak & 
Wilkinson, 1984) compared to those offspring exposed to less than that amount or not at all. In 
addition, first trimester heavy PME was also associated with offspring anxiety as measured by 
the Revised Children’s Manifest Anxiety Scale (RCMAS; Reynolds and Richmond, 1978; 
Goldschmidt et al., 2004). 
In the OPPS cohort, PME was associated with deficits in attention at ages 13-16 (Fried & 
Watkinson, 2001). Day and colleagues (2011) found that PME was associated with delinquency 
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in offspring at age 14 in the MHPCD cohort and that this association was mediated by attention 
problems and depressive symptoms. Findings from the MHPCD cohort demonstrated that PME 
was also associated with deficits in academic achievement at age 14 as measured by the 
Wechsler Individual Achievement Test (WIAT) Screener (Psychological Corporation, 1992; 
Goldschmidt, Richardson, Willford, Severtson, & Day, 2012). PME predicted poorer reading 
scores and the composite scores (reading, math, and spelling) on the WIAT but the effect was 
mediated by intelligence score, attention, depressive symptoms, and early initiation of marijuana 
(Goldschmidt et al., 2012). 
At age 16, a subsample of 320 offspring of the MHPCD cohort completed a bimanual 
coordination test, and the results showed third trimester PME was associated with decreased 
processing speed and interhemispheric coordination (Willford, Chandler, Goldschmidt, & Day, 
2010). At ages 18-22, Smith and colleagues (2004) reported findings from an fMRI study 
conducted on the OPPS cohort and concluded that offspring with PME committed more errors of 
commission on a blocked design Go/No-Go task than those unexposed offspring, suggesting 
impulsivity.  
In conclusion, the findings of these two cohort studies demonstrate that PME affects 
offspring behavior from birth through adolescence.  
1.5.4 Prenatal marijuana exposure and offspring marijuana use 
To date, the MHPCD and OPPS cohorts are the only studies to evaluate whether PME is a 
significant predictor of offspring marijuana use. Findings from the MHPCD cohort demonstrated 
that PME, defined as a continuous value of self-reported average number of daily joints, 
significantly predicted the age of initiation of marijuana in the offspring at age 14 (HR=1.14), as 
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well as the frequency of marijuana use (OR=1.30) (Day et al., 2006). In the OPPS cohort, PME, 
defined as a dichotomous variable indicating whether women used marijuana or abstained, 
predicted initiation of marijuana (OR=2.76, 95% CI: 1.11-6.86) but did not predict marijuana use 
in offspring between the ages of 16 and 21 years (OR=0.79, 95% CI: 0.33-1.90) (Porath & Fried, 
2005). Additionally, there was an interaction by gender in the OPPS cohort: males initiated 
marijuana at a faster rate compared to females (Porath & Fried, 2005). This interaction was not 
evaluated in the MHPCD cohort (Day et al., 2006). The association between PME and offspring 
use in young adulthood has not yet been evaluated.  
1.6 SUMMARY 
In summary, PME affects the CNS of the developing offspring, changing cognition, emotion 
regulation, and behavior. Prior studies determined that PME was associated with offspring age of 
marijuana initiation, frequency of marijuana use, behavior problems, and neurocognitive 
function. By young adulthood, marijuana initiation is likely to have occurred and use is most 
frequent. Therefore, young adulthood is a significant time point to evaluate the effects of PME. 
In this dissertation, we evaluate the effects of PME on offspring frequency of marijuana use and 
CUD at 22 years. We also examined pathways from PME to frequency of marijuana use and 
CUD using intervening variables identified in prior studies. To date, there are no published 
findings on this topic, making the papers presented here unique contributions to the literature.  
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1.7 SPECIFIC AIMS AND HYPOTHESES 
The goal of this dissertation was to examine the effect of prenatal marijuana exposure on 
offspring frequency of marijuana use and CUD in young adulthood. The specific aims and 
hypotheses for each paper are described below. 
1.7.1 Prenatal marijuana exposure as a predictor of offspring marijuana use in young 
adulthood 
The first aim of this paper was to evaluate the association between PME and offspring frequency 
of marijuana use in young adulthood. The hypothesis was that PME would significantly predict 
offspring frequency of use in young adulthood. The second aim was to determine whether the 
gender, race, or history of childhood maltreatment moderated the association between PME and 
offspring frequency of marijuana use in young adulthood. The second hypothesis was that this 
finding would remain significant after adjusting for covariates. A third hypothesis was that 
gender, race, and history of childhood maltreatment moderated the association between PME and 
offspring frequency of marijuana use in young adulthood. 
At 22 years, a sample of 589 individuals was available for analysis, representing 77% of 
the birth cohort. PME was defined as a continuous variable, average daily joints used by the 
mother during the first trimester. Offspring marijuana use was ascertained for the past year and 
the categories were defined as: no use, using less than three times per week, and using at least 
three times per week. A simple ordinal logistic regression model was used to test the significance 
of the first hypothesis. The second hypothesis was tested using a multivariable ordinal logistic 
regression model. Covariates were selected based on a search of the literature, prior experience 
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with this dataset, and the statistical significance with the exposure and outcome. The hypotheses 
about moderation were tested separately using the multivariable ordinal logistic regression 
model. A separate interaction term was created between PME and each moderator.  
1.7.2 From prenatal marijuana exposure to offspring frequency of marijuana use in 
young adulthood: A path analysis 
The aim of this paper was to examine pathways from PME to offspring frequency of marijuana 
use in young adulthood. We hypothesized that there would be a significant direct effect from 
PME to offspring frequency of marijuana use. We also hypothesized that we would observe 
significant indirect effects of PME on offspring frequency of marijuana use through the 
following intervening variables: offspring depressive symptoms, anxiety, attention, delinquent 
behavior at 10 years of age, and parental authoritativeness at age 16, as well as early onset of 
marijuana use. Early initiation of marijuana was defined as never used, first use ≥16 years, and 
first use <16 years. A path analysis was conducted to determine the significance of individual 
paths and the overall indirect effect of PME on use through the intervening variables. 
1.7.3 From prenatal marijuana exposure to offspring cannabis use disorder in young 
adulthood: A path analysis 
The aim of this paper was to examine the role of offspring depressive symptoms and early 
initiation of marijuana as variables in the pathway from PME to CUD. We hypothesized that 
there would be a significant direct effect of PME on CUD. We also hypothesized that there 
would be a significant indirect effect of PME on CUD through the intervening variables of 
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offspring depressive symptoms and early initiation of marijuana. Offspring depressive symptoms 
were self-reported at age 10 and early initiation of marijuana was defined as first use before age 
16, first use at age 16 or older, and never used. Offspring CUD was determined from a structured 
interview. A path analysis was conducted to determine the significance of individual paths and 
the overall indirect effect of PME on CUD through the intervening variables.  
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2.1 ABSTRACT 
Background. Prenatal marijuana exposure (PME) affects the developing CNS, which may affect 
offspring behavior. Prior studies have shown that PME is a significant predictor of marijuana 
initiation and frequency of marijuana use during adolescence, after controlling for other prenatal 
exposures and current environment. The objective of this study was to determine whether this 
finding was observed in young adulthood.  
Methods. The present study evaluated the effect of PME on frequency of marijuana use in 
offspring at 22 years of age and tested variables that may moderate this association. Women 
were recruited from a prenatal clinic in Pittsburgh, Pennsylvania from 1982-1985 when they 
were in their fourth month of pregnancy. At 22 years, frequency of offspring marijuana use was 
defined as no use, using less than three times per week, and using three or more times per week. 
Using an ordinal logistic regression model, analyses were performed on 589 mother-offspring 
pairs, representing 77% of the birth cohort. 
Results. PME significantly predicted frequency of marijuana use in offspring at 22 years, 
suggesting that the odds of higher frequency of use increased as PME increased. These findings 
remained significant controlling for prenatal alcohol exposure and offspring demographic 
characteristics. However, this finding was no longer significant after controlling for the home 
environment, maternal marijuana use during offspring childhood, and the offspring’s self-
reported history of childhood maltreatment. The association between PME and offspring use was 
moderated by a history of childhood maltreatment, but not by race or gender.  
Conclusions. The initial association between PME and frequency of marijuana use in 
young adulthood was not significant after controlling for environmental and psychosocial 
influences. The interaction between PME and offspring childhood maltreatment suggested that 
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PME was associated with offspring frequency of use at low levels of childhood maltreatment, 
but not at high levels of childhood maltreatment. Future directions of this research include 
examining pathways from PME to offspring frequency of marijuana use. 
2.2 INTRODUCTION 
Marijuana is the most widely used illicit substance in the world, with recent estimates from the 
United Nations Office on Drugs and Crime indicating that 2.5%-5% of the world’s population 
reported using cannabis in the past year (Danovitch & Gorelick, 2012; United Nations Office on 
Drugs and Crime [UNODC], 2012). In the US, the average age of marijuana initiation is 17.5 
years (Substance Abuse and Mental Health Services Administration [SAMHSA], 2012). Use is 
highest between the ages of 15-30 and typically declines after that time (Sundram, 2006). Males 
typically have higher rates of use than females, but this gender gap may be narrowing (Perkonigg 
et al., 2008; SAMHSA, 2012; von Sydow et al., 2001; Wallace et al., 2003). In addition, national 
survey data of middle and high school students indicate that use is highest among Native 
Americans, followed by Hispanics, whites, blacks, and Asian-Americans (Wallace et al., 2003).  
Other influences have been shown to play a role in marijuana initiation and use. The 
effects of genetics on marijuana use have been demonstrated using twin studies and family 
histories of substance use problems (Agrawal & Lynskey, 2006; von Sydow, Lieb, Pfister, 
Hofler, & Wittchen, 2002). Environmental factors associated with use include leaving the family 
home before the age of 18, family conflict, change in mother’s marital status, maternal smoking 
and marijuana use when the offspring was an adolescent, parental supervision and control, and 
peer marijuana use (Day, Goldschmidt, & Thomas, 2006; Hayatbakhsh et al., 2008; 
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Hayatbakhsh, Najman, Bor, O'Callaghan, & Williams, 2009; Perkonigg et al., 2008; Richardson, 
Larkby, Goldschmidt, & Day, 2013; von Sydow et al., 2002).   
Psychosocial factors associated with use include having an antisocial personality 
diagnosis, low self-competence, distressing life events, having a high number of symptoms of 
depression and anxiety, aggressive and delinquent behavior, and a history of childhood 
maltreatment, particularly sexual and physical abuse (Hayatbakhsh et al., 2009; Hussey, Chang, 
& Kotch, 2006; Kilpatrick et al., 2000; Lo & Cheng, 2007; Perkonigg et al., 2008).     
One understudied factor is how prenatal marijuana exposure (PME) is associated with 
offspring marijuana use. Marijuana is a commonly-used illicit substance during pregnancy. 
Findings from the National Pregnancy and Health Survey conducted in 1992-1993 indicate that 
2.9% of women used marijuana at some point during pregnancy (National Institute on Drug 
Abuse [NIDA], 1996). Use during pregnancy has the potential to disrupt the endogenous 
cannabinoid system (ECS) of the developing fetus.  When marijuana is consumed, the main 
psychoactive ingredient, delta-9-tetrahydrocannabinol (THC), enters the mother’s bloodstream 
and crosses the placenta (Sundram, 2006). These exogenous cannabinoids bind to receptors in 
the developing ECS.  The ECS is important in the development of the CNS and is associated 
with progenitor cell migration and differentiation, neuronal migration, development of axonal 
pathways, and the creation of functional synapses (Gaffuri, Ladarre, & Lenkei, 2012; Wu, Jew, 
& Lu, 2011). Animal models also demonstrate that PME affects the endogenous opioid, 
dopamine, and serotonin systems (Jutras-Aswad, DiNieri, Harkany, & Hurd, 2009). Taken 
together, these changes may put offspring at risk for problems with emotion regulation, memory, 
depression, and addiction later in life (Jutras-Aswad et al., 2009). 
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There are two birth cohorts with published findings on long-term outcomes of PME: the 
Maternal Health Practices and Child Development (MHPCD) Study and the Ottawa Prenatal 
Prospective Study (OPPS).  These studies have found that PME predicted deficits in memory and 
attention, increases in impulsivity and hyperactivity; symptoms of anxiety and depression, and 
delinquent behavior  (Day, Leech, & Goldschmidt, 2011; Day et al., 1994; Fried, Watkinson, & 
Gray, 1992; Fried & Watkinson, 1990; Fried & Watkinson, 2001; Goldschmidt, Day, & 
Richardson, 2000; Goldschmidt, Richardson, Cornelius, & Day, 2004; Gray, Day, Leech, & 
Richardson, 2005; Leech, Richardson, Goldschmidt, & Day, 1999). Some of these effects of 
PME have also been shown to be associated with marijuana use as described above.  
Earlier findings published on the MHPCD cohort demonstrated that PME predicted early 
onset of use, defined as initiation of marijuana in the offspring by age 14 (HR=1.14), as well as 
the frequency of marijuana use (OR=1.30) (Day et al., 2006). In the OPPS cohort, PME 
predicted age of initiation of marijuana (OR=2.76, 95% CI: 1.11-6.86), but did not predict 
frequency of marijuana use in offspring between the ages of 16 and 21 years (OR=0.79, 95% CI: 
0.33-1.90) (Porath & Fried, 2005). Additionally, an interaction was found with gender. The 
results suggested that males initiated marijuana at a faster rate than females (Porath & Fried, 
2005). This interaction was not assessed in the MHPCD cohort (Day et al., 2006).  
Race and childhood maltreatment are other factors that may interact with PME and affect 
offspring marijuana use, but these findings have not been reported in either cohort. This 
interaction between race and PME was not reported in the OPPS cohort (Porath & Fried, 2005). 
This was likely because it could not be tested, as the cohort was predominately composed of 
Caucasian women. This interaction was not reported in the MHPCD cohort at 14 years but it can 
be tested due to the racial heterogeneity of the sample (Day et al., 2006). To date, childhood 
 28 
maltreatment findings have not been reported in the OPPS cohort and its association with PME 
has not yet been evaluated in the MHPCD cohort. Prenatal substance use has been associated 
with an increased risk of offspring childhood maltreatment (Jaudes, Ekwo, & Van Voorhis, 
1995; Smith, Johnson, Pears, Fisher, & DeGarmo, 2007). Further, childhood maltreatment has 
been associated with substance use later in life (Hussey et al., 2006; Kilpatrick et al., 2000; Lo & 
Cheng, 2007). Therefore, evaluating this interaction represents a novel and meaningful 
contribution to the literature. 
In summary, few studies involving longitudinal data have been conducted to evaluate the 
effects of PME on offspring marijuana use. To date, the published findings of this association 
were found when the offspring were 14 years on average in the MHPCD cohort and ranged from 
16-21 years in OPPS cohort. There have been no publications from birth cohorts evaluating the 
association between PME and offspring use in young adulthood. It is important to evaluate this 
association for two reasons. One, the average age of marijuana initiation has consistently been 
reported to be in the teenage years (SAMSHA, 2012). Thus, initiation is likely to have occurred 
by young adulthood. Two, levels of substance use are highest during young adulthood, 
suggesting it is developmentally appropriate to evaluate the effect of PME on offspring 
marijuana at this time point (Spoth, Trudeau, Guyll, Shin, & Redmond, 2009). This paper also 
offers insight about the relationship between PME and offspring marijuana use in young 
adulthood in a low socioeconomic, racially diverse sample. 
In this paper, we aim to determine the association between PME and marijuana use in 
early adulthood. We hypothesize that:  1) PME will predict offspring use of marijuana in early 
adulthood, 2) the association between PME and offspring use will remain significant after 
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controlling for covariates, and 3) the effects of PME on marijuana use in offspring in early 
adulthood will be moderated by offspring gender, race, and childhood maltreatment.  
2.3 METHODS 
2.3.1 Sample description 
The data for this study come from the Maternal Health Practices and Child Development 
(MHPCD) study at the University of Pittsburgh. This is a longitudinal study of the effects of 
prenatal exposure to alcohol and marijuana on offspring development. The participants were 
recruited from a prenatal clinic at Magee-Womens Hospital in Pittsburgh, PA. Recruitment took 
place from 1982-1985. Eligible women had to speak English, be at least 18 years of age, and be 
in their fourth or fifth gestational month. There was a 15% refusal rate. There were 1,360 women 
who completed an initial interview about substance use in the first trimester. These substances 
were alcohol, tobacco, marijuana, and other illicit drugs.  
The initial interview was administered to select two cohorts. One cohort was composed 
of women who drank three or more alcoholic drinks per week in the first trimester and a random 
sample of one-third of those women who drank less than this amount or not at all. The second 
cohort was composed of women who used marijuana at least two times per month in the first 
trimester and a random sample of one-third of those women who reported they used less 
marijuana or none at all. Sampling was done with replacement allowing women to be eligible for 
both cohorts. Participants followed the same protocols, which allowed the study cohorts to be 
combined for analysis. The combined cohort was composed of 829 women with 60% overlap 
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between the alcohol and marijuana cohorts. Informed consent was obtained from the women and 
this study was approved by Magee-Womens Hospital and the Institutional Review Board of the 
University of Pittsburgh. 
The women enrolled in the MHPCD study were interviewed again in their 7th gestational 
month. Subsequent assessments of mothers and offspring were conducted after the offspring’s 
birth, 8 and 18 months, and 3, 6, 10, 14, 16, and 22 years of age. At each phase of data 
collection, information was gathered about maternal psychological, social, and environmental 
factors, demographic status, and substance use, and the children's cognitive, behavioral, 
psychological, and physical development. 
The birth cohort consisted of 763 live singleton infants. The reasons for the loss of 
participants at birth were that 8 individuals refused the delivery assessment, 16 women were lost 
to follow-up, and 21 women moved out of the area. Other exclusions included 18 offspring due 
to early fetal death, two offspring due to multiple gestation birth, and one offspring was placed 
for adoption and could not be followed. Only those mother-child pairs who completed the 
assessment at birth were selected for follow-up. 
At the 22-year phase, 608 offspring participated in an interview, representing 80% of the 
birth cohort. Among the 155 who did not participate, 30 individuals refused, 3 had been adopted 
and could not be located, 18 were institutionalized in either jail or a rehabilitation facility, 56 
were lost to follow-up, 29 had moved out of the area, 11 had died, and 8 could not participate 
due to low cognitive functioning. Fourteen individuals did not complete the instrument about 
childhood maltreatment used in this analysis, and five individuals were excluded because they 
reported that they had not used marijuana but tested positive for the substance on a urine screen. 
This resulted in a final sample size of 589, representing 77% of the birth cohort. Those who were 
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included in the analysis (n=589) did not differ from those who were not included in the analysis 
(n=174) based on maternal characteristics assessed at the first trimester visit including age, race, 
education, marital status, household income, and substance use (Appendix, Table 10). 
2.3.2 Measures 
2.3.2.1 Prenatal marijuana exposure 
The mothers provided information about the pattern of their marijuana use at each assessment. A 
series of questions developed for the MHPCD study measured usual, maximum, and minimum 
quantity and frequency (Day & Robles, 1989). The same questions were asked about use of 
hashish and sinsemilla. Conversions of hashish and sinsemilla were done to account for the 
higher THC content in those substances. One joint of sinsemilla was equal to two joints of 
marijuana, one joint or bowl of hashish was equal to three joints of marijuana (Gold, 1989; 
Hawks, 1986; Julien, 1988). A blunt was scored as the self-reported number of joints in the 
blunt. If the participant did not report the number of joints in the blunt, then it was coded as four 
joints. Marijuana use was calculated as the average daily joints (ADJ). The ADJ formula is: 
(number of joints/week x 4 weeks/month)/31 days/month. An ADJ of 0.4 is equivalent to using 
three joints per week and an ADJ of 0.89 is equivalent to using one joint per day. A bogus 
pipeline was used to encourage accurate reporting of substance use at the first phase (Jones & 
Sigall, 1979). 
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2.3.2.2 Offspring frequency of marijuana use 
Marijuana use among the offspring was measured with the same questions and conversions 
described above. The frequency categories were collapsed to no use, use <3 times per week, and 
use ≥3 times per week to be consistent with a prior analysis using this data set (Day et al., 2006).  
2.3.2.3 Covariates 
We considered covariates identified in the literature and based on prior findings of this cohort. 
We evaluated the following maternal demographic covariates assessed at the first interview: age, 
race, years of education, and household income. We considered the psychological factors of 
depressive symptoms, anxiety, and hostility. The mothers completed the Center for 
Epidemiological Studies-Depression Scale (CES-D; Radloff, 1977) to provide an assessment of 
depressive symptoms. This is a 20-item self- report questionnaire in which respondents indicate 
their symptoms on a Likert scale. They completed the State-Trait Anxiety Inventory 
(Spielberger, 1970), which assessed anxiety and hostility. This questionnaire is also a self-
reported measure of symptoms using a Likert scale. Finally, we considered use of alcohol, 
cigarettes, and other illicit drugs during the first trimester. Alcohol use was defined as the 
average number of drinks (Average Daily Volume [ADV]) consumed per day using the same 
formula described above for ADJ.  Cigarette use was expressed as the number of cigarettes 
smoked per day. The use of cocaine and other illicit drugs were dichotomized due to the low 
frequency of use in this sample.  
When the offspring were 10 years of age, the mothers provided information about their 
own substance use using the same procedure described above. They also reported information 
about the home environment in which the offspring were being raised. The Home Observation 
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for Measurement of the Environment-Short Form (HOME; Baker & Mott, 1989) was used to 
measure the home environment in regard to cognitive stimulation and emotional support.  
At 16 years of age, the offspring reported the number of friends they had who used 
alcohol, cigarettes, and marijuana. These variables were collapsed into dichotomous variables to 
indicate whether they had friends who used these substances. Parenting was assessed using the 
My Parents (Steinberg, Lamborn, Dornbusch, & Darling, 1992) tool. The offspring completed 
this questionnaire and scores were ascertained for scales related to parental 
acceptance/involvement, supervision/strictness, and psychological autonomy granting. These 
subscales are used to create a composite of an overall score of authoritativeness. A score above 
the median on a subscale is coded as one and the sum is added for a maximum of three. The 16-
year phase for the peer and parenting variables was chosen because we wanted to look at 
influences during adolescence based on the literature search.  
At 22 years, the offspring reported whether their mothers, fathers, or siblings had a 
history of problems with alcohol or drugs. A dichotomous variable for family history of 
problematic use was created to represent whether the offspring had a first degree relative with 
such problems. Offspring also provided information about demographic characteristics and their 
own use of other substances during the interview. 
2.3.2.4 Moderators 
Interaction terms were created to test whether the effects of PME differed by offspring gender, 
race, and childhood maltreatment. Gender was ascertained during the assessment that took place 
at birth. Offspring race was self-reported during the 22-year assessment. Offspring child 
maltreatment was assessed at 22 years of age using the Child Trauma Questionnaire (CTQ; 
Bernstein & Fink, 1998). The CTQ contains 25 items that assess whether an individual 
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experienced the following five types of abuse: emotional abuse, physical abuse, sexual abuse, 
emotional neglect, or physical neglect when they were growing up. Respondents use a 5 point 
Likert scale ranging from never true to very often true. The scores for the subscales range from 5 
to 25. The subscales were dichotomized to indicate whether an offspring had experienced 
moderate to severe abuse using the following suggested cut points: ≥13 for emotional abuse, ≥10 
for physical abuse, ≥8 for sexual abuse, ≥15 for emotional neglect, and ≥10 for physical neglect 
(Bernstein & Fink, 1998). A sum of the five dichotomous scales was used in this analysis.  
2.3.3 Analysis plan 
Analyses were performed on the combined cohort. We restricted our analysis to the first 
trimester for two reasons. First, fewer women participated in the second study visit. 
Approximately 10% of the participants did not complete the interview for the second trimester. 
Second, marijuana use declined during pregnancy. While 41% of the women reported marijuana 
use during the first trimester, only 18% reported use by the third trimester (Figure 1). Therefore, 
analyzing the data based on the first trimester only allowed us to maximize the sample size. 
Table 11 of the Appendix displays the sample sizes and marijuana use of the mothers across 
gestation. 
The covariates considered for the analysis were based on a review of the literature and 
prior analyses performed on this data set. There were covariates with missing data and the range 
of missing was 0.2%-16%. Values were calculated using multiple imputation by chained 
equations (MICE). MICE can perform imputation of continuous, dichotomous, and ordinal 
variables (Royston & White, 2011). Ten data sets were imputed to ensure the efficiency of the 
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estimates was above 95% (Rubin, 1987). Our efficiency with 16% missing was 98%. The final 
analysis was done using the pooled estimates of the imputed datasets.  
The distributions of marijuana and alcohol variables were examined. Out of range values 
for marijuana were set to 10.0 joints per day and the out of range values for alcohol use were set 
to 8.0 drinks per day.  
Descriptive statistics were generated to explore the associations between the variables 
considered for this analysis. We looked at the correlations and performed t-tests or analysis of 
variance (ANOVA) to evaluate continuous variables. For those continuous variables that were 
not normally distributed, we used the Mann-Whitney U test or the Kruskal-Wallis test. We 
performed Chi-square tests to evaluate the association between dichotomous variables. Cohen’s 
d and Cramer’s V were calculated to assess effect size. The effect size is a statistic used to 
quantify the differences between the groups. 
To assess the first hypothesis evaluating the association between PME and offspring use, 
we performed a univariable ordinal logistic regression model. The second hypothesis was that 
the association between PME and offspring use would remain significant after controlling for 
covariates. To test this hypothesis, variables significantly associated with the exposure and the 
outcome at p<.05 were identified. Our final model included these significant variables and those 
relevant from the literature. We also hypothesized that the association between PME and 
offspring use would be moderated by gender, race, and childhood maltreatment. An interaction 
term was created between PME and each moderator. Moderation was tested separately for each 
term to avoid oversaturation of the final model. 
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2.4 RESULTS 
Characteristics of the sample for this analysis are displayed in the Appendix, Table 12. During 
the first prenatal visit, the women recruited for this study were 23 years of age, on average, and 
ranged from 18-42 years. Fifty-one percent of the women were African American and 32% were 
married. The women completed 11.8 years of education and 25% were in school and/or working 
outside the home. The sample was composed predominantly of low income women with 61% 
reporting a monthly household income of less than $400. Maternal substance use in the first 
trimester is also reported. Forty-one percent of the women reported using marijuana and the 
average daily joints was 0.37, indicating use occurred about three times per week. Sixty-four 
percent of women reported using any alcohol with average daily volume of 0.55, and 53% 
reported smoking cigarettes. Four percent of the mothers reported using cocaine and 9% reported 
using other illicit drugs such as heroin or LSD. 
At birth, 47% of the offspring were male. On average, the offspring were born at about 
40 weeks gestation with 8% born preterm (before 37 weeks). The average birth weight was 3.20 
kg and 10% were of low birth weight (<2500g).  
At 10 years, the average score was 12.7 (range: 3-18) on the HOME measure. This is the 
total of the cognitive stimulation and emotional support scales with a higher score indicating a 
more stimulating and supportive environment. Maternal substance use was reported at this time. 
Twenty-one percent reported using marijuana, 78% reported using alcohol, 59% reported using 
cigarettes, and 8% reported using other illicit drugs. 
At 16 years, mean scores for the acceptance/involvement, psychological autonomy, and 
strictness/supervision subscales on the My Parents instrument were 30 (range: 15-36), 24 (range: 
9-36), and 19 (range: 8-30), respectively. Higher scores indicate that offspring believe their 
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parents are more loving and involved, allow offspring to express individuality, and monitor 
offspring and set limits (Steinberg et al., 1992). The overall authoritativeness score was 1.42, 
demonstrating parenting is considered to be between somewhat nonauthoritative to somewhat 
authoritative (Steinberg et al., 1992). Over 70% of offspring reported that they had at least one 
friend who used alcohol, tobacco, or marijuana.  
At the 22-year assessment, the offspring were 22.8 years old, on average, and 56% 
identified their race as African American. The average number of years of education completed 
was 12.8 and 87% of the offspring had completed high school. Sixty-one percent were working 
and/or in school and the median monthly personal income was $800. Thirty-five percent were 
living with their mother or caregiver. Only 6% of the offspring were married and 36% had at 
least one child. Over 80% had initiated cigarettes and marijuana and 99% had initiated alcohol. 
Past-year cigarette use was reported by 43% of respondents. Fifty percent of the offspring used 
marijuana in the past year and 93% reported using alcohol in the past year. Forty-seven percent 
of the offspring reported that a first degree relative had problems with alcohol or drugs. Twenty-
nine percent reported experiencing moderate, severe, or extreme child maltreatment. The mean 
child maltreatment score was 2.43 (range: 1-5). 
Table 1 presents characteristics of the sample according to maternal marijuana use in the 
first trimester. For descriptive purposes, categories were created representing women who did 
not use marijuana during the first trimester, those who used less than one joint per day (light to 
moderate use), and those who used one or more joints per day (heavy use). Mothers who were 
using marijuana during the first trimester were more likely to be African American, unmarried, 
not working outside the home or in school, report a lower monthly household income, and use 
other substances. There were no significant differences by offspring gender, gestational age, or 
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birth weight. When the offspring were 10 years of age, the mean HOME scores were not 
significantly different for the categories of marijuana use. Mothers who used marijuana during 
the first trimester had higher percentages or mean quantities of licit and illicit substances when 
their offspring were 10 years of age. When the offspring were 16 years of age, there were no 
significant differences on any of the My Parents subscales. Those with PME were not more 
likely to have peers who used cigarettes and alcohol, but there was a marginally significant 
difference for peer marijuana use. Those with PME reported a higher percentage of peers who 
used marijuana, compared to those without PME.  
At 22 years, those without PME were older than those with PME. African American 
offspring were more likely to have PME than those who were Caucasian. There no significant 
differences by years of education, personal income, percent working or in school, marital status, 
living with a mother or caregiver, or having at least one child. Those in the heavy PME group 
had a marginally significant higher mean score on the CTQ than those with light to moderate 
PME and those unexposed. There were no differences according to a family history of drug or 
alcohol problems. There were no significant differences in initiation or past-year use of alcohol 
or cigarettes. There were differences in marijuana initiation and frequency of use. Offspring 
across all levels of PME had a higher percentage of marijuana initiation and a higher frequency 
of marijuana use compared to those without PME.  There were no significant differences in past-
year use of cocaine or other illicit drugs.  
Among the non-users at 22 years, 66% had no PME, 24% had light to moderate exposure, 
and 10% had heavy exposure (Table 2). This is in contrast to the most frequent users at 22 years, 
where 44% had no PME exposure, 36% had light to moderate exposure, and 20% had heavy 
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exposure. This relation between PME and offspring use was statistically significant with a p-
value of 0.001. 
Model 1 tested the crude association between PME and offspring use (Table 3). The 
association was significant (p = 0.003; OR = 1.28 (95% CI: 1.09-1.51)). As PME increased by 
one joint per day, the odds of the offspring being in a higher category of use increased by 1.28. 
In Model 2, first trimester prenatal alcohol exposure and offspring race, gender, and age at the 
22-year assessment were added. PME remained a significant predictor of offspring use with a p-
value of 0.019. Adjusting for these covariates, a one unit increase in PME increased the odds of 
being in a higher category of use by 1.22. 
Model 3 built on the prior model by adjusting for maternal marijuana use at 10 years, the 
home environment at 10 years, and the offspring’s self-reported history of childhood 
maltreatment. In this model, PME was no longer a significant predictor of offspring use (p= 
0.182) after adjusting for selected covariates in the full model. Although maternal marijuana use 
at 10 years and the offspring’s home environment at 10 years were not significant factors in the 
adjusted model, the remaining covariates were significant. The results of this model indicated 
that the odds of being in a higher category of use were higher for males (OR = 1.98 (95% CI: 
1.44-2.73)) and lower for Caucasians (OR = 0.70 (95% CI: 0.50-0.98)). The odds of being in a 
higher category of use increased as prenatal alcohol exposure (OR = 1.18 (95% CI: 1.03-1.35)) 
and childhood maltreatment scores (OR = 1.23 (95% CI: 1.07-1.42)) increased. However, the 
odds decreased as age at the time of the 22-year assessment increased (OR = 0.77 (95% CI: 0.61-
0.97)), indicating that the younger offspring were more likely to be in a higher category of use. 
The last aim of this paper was to evaluate whether gender, race, and a history of child 
maltreatment moderated the association between PME and offspring use at 22 years (Table 4). In 
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Model 4, the interaction term created for PME and gender was not significant. After adjusting for 
the covariates in the model, the p-value of the interaction term was 0.228 and the odds ratio was 
1.25 (95% CI: 0.087-1.81). In Model 5, the interaction term created for PME and race was not 
significant with a p-value of 0.404 and an odds ratio of 1.21 (95% CI: 0.78-1.87). Neither gender 
nor race was a significant moderator of the association between PME and offspring frequency of 
marijuana use at 22 years.   
The interaction between PME and childhood maltreatment was significant (p= 0.004; OR 
= 0.85 (95% CI: 0.75-0.95)). In the absence of PME (ADJ=0), the probability of using marijuana 
at 22 years was higher as the childhood maltreatment scores increased (Figure 2). In the presence 
of PME, offspring with a low childhood maltreatment score increased the likelihood of 
marijuana use at 22 years at a faster rate than offspring with a high childhood maltreatment 
score. This suggests that in the absence of moderate, severe, or extreme childhood maltreatment, 
PME contributed to the prediction of frequency of marijuana use in the young adult offspring. 
However, when offspring experienced high levels of childhood maltreatment and had higher 
PME, then PME was not as influential in the prediction of offspring frequency of marijuana use 
at 22 years. 
2.5 DISCUSSION 
The aim of this study was to evaluate whether PME was a significant predictor of offspring 
marijuana use in young adulthood. The crude association between these variables was 
significant, and the finding remained significant after controlling for prenatal alcohol exposure, 
offspring race, offspring gender, and offspring age. However, this finding was not significant 
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when controlling for the offspring’s home environment, maternal marijuana use when offspring 
were 10 years of age, and the offspring’s history of childhood maltreatment. Further, we 
determined that gender and race did not moderate the association between PME and offspring 
marijuana use at 22 years. The interaction between PME and offspring child maltreatment 
suggested that PME was associated with offspring frequency of use at low levels of childhood 
maltreatment, but not at high levels of childhood maltreatment.  
The findings of this paper build on prior reports of this study. When the offspring were 
14 years old, PME was a significant predictor of use after adjusting for several confounders 
including the home environment, parenting, peer use, offspring behavior, and current offspring 
use of other substances (Day et al., 2006). In contrast, we did not find a significant association at 
age 22 after we adjusted for similar factors. One reason for this may be because of the 
significance of childhood maltreatment in our model. Childhood maltreatment had not been 
assessed in earlier phases of the MHPCD study. Thus, it could not be accounted for in the 
analyses until this 22-year assessment.  
Although Porath and Fried (2005) did not find that gender modified the association 
between PME and offspring frequency of marijuana use in that sample, this was tested in our 
analysis because of the preponderance of male users. Our findings confirm the reports from the 
OPPS that PME does not affect offspring frequency of marijuana use differently for males and 
females. We also concluded that, although marijuana use was more common among African 
American mothers, race did not moderate the association between PME and offspring frequency 
of marijuana use. This is an important contribution to the literature as this hypothesis was not 
tested in the OPPS cohort, presumably due to the racially homogenous sample (Porath & Fried, 
2005). 
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The observed interaction between PME and offspring childhood maltreatment was 
surprising in that the effect of PME was stronger for those who reported less childhood 
maltreatment. A theory as to why this may occur is that those who experience childhood 
maltreatment are already at risk for substance use in adulthood, thus PME had no additional 
influence to contribute (Lo & Cheng, 2007). By contrast, PME was an additional risk factor for 
the offspring who did not experience such childhood maltreatment. In light of this speculation, 
this finding needs further investigation in future studies. 
This study has several strengths. The study had a large sample size of 589 individuals and 
excellent follow-up rates: 77% of the birth cohort was seen at age 22. Second, this study 
recruited approximately equal numbers of African American and Caucasian women during the 
early 1980s, allowing for an analysis of a racially heterogeneous sample. Third, the data for this 
study were obtained prospectively, which minimizes recall bias. 
There are some notable limitations to this analysis. This sample is composed of 
predominately low income women, and the results may not be generalizable to women in higher 
socioeconomic groups. Additionally, marijuana use was ascertained by self-report. However, a 
bogus pipeline procedure was used to encourage honest reporting from mothers at the first 
prenatal visit. In addition, a urine screen was part of the study protocol for the offspring at the 
22-year visit. Among those who reported they did not use marijuana, only 2% screened positive. 
Among those who reported that they used marijuana in the past year, 64% had positive results on 
the urine screen. While the results of the urine screen can only offer insight about recent 
marijuana use, they do suggest that participants are being honest about their use. Further, the 
staff members who interviewed the participants were comfortable asking questions about the 
sensitive topics (e.g., substance use, psychosocial factors) and followed an established protocol 
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for the sequence of questioning. In addition, a National Institutes of Health Certificate of 
Confidentiality was obtained for this study because of the sensitive nature of topics discussed. 
This provides research participants with a sense of confidentiality and privacy because it offers 
protection from the release of identifying information when requested through court order or 
subpoena (National Institutes of Health). 
In summary, the findings of this analysis suggest that PME predicted offspring marijuana 
use in young adulthood, but this finding was no longer significant after controlling for 
environmental and psychosocial factors. A future direction of this research will be to examine 
variables in the pathway from PME to offspring frequency marijuana use in young adulthood, 
including depressive symptoms and early initiation of marijuana. 
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2.7 TABLES AND FIGURES 
Table 1. Sample characteristics by category of first trimester marijuana use 
 Maternal Marijuana Use 
 
No usea 
(n=347) 
Light to 
moderate 
useb 
(n=165) 
Heavy 
usec 
(n=77) p-valued 
Effect 
sizee 
Maternal Characteristics at the First Trimester Visit 
Age (mean years) 23.32 22.61 22.84 0.161 0.006 
Race (% African American)  45.53 52.73 75.32 <0.001 0.196 
Education (mean years) 11.85 11.84 11.72 0.760 0.001 
Marital status (% married) 37.46 27.27 18.18 0.001 0.150 
Employment status (% in school or 
working outside the home) 
25.36 30.91 14.29 0.022 0.114 
Household income (%<US$400/month)f 57.10 64.63 73.33 0.020 0.117 
Depression (mean CES-D score)g 20.83 21.10 21.26 0.894 <0.001 
Anxiety (mean STPI score)h 17.58 17.93 18.01 0.627 0.002 
Hostility (mean STPI score)h 18.30 19.11 19.83 0.063 0.009 
Any alcohol use (%) 55.33 78.18 74.03 <0.001 0.222 
Average daily volume of alcohol 0.40 0.75 0.78 <0.001 0.027 
Any cigarette use (%) 47.26 60.00 64.94 0.002 0.144 
Average daily cigarettes 7.68 8.65 9.38 0.410 0.003 
Any cocaine use (%) 1.73 5.45 9.09 0.003 0.139 
Any other drug use (%) 6.92 9.70 15.58 0.047 0.102 
Offspring Characteristics at Birth 
Gender (% male) 47.84 47.27 44.16 0.842 0.024 
Gestational age (mean weeks) 39.71 39.96 39.84 0.460 0.003 
Preterm birth (% <37 weeks) 8.36 8.48 6.49 0.849 0.024 
Birthweight (mean kg) 3.21 3.22 3.08 0.172 0.006 
Low birth weight (%<2500g) 9.51 10.91 10.39 0.880 0.021 
Characteristics at 10 Years 
Home environment scorei 12.89 12.50 12.37 0.186 0.007 
Maternal average daily jointsj 0.02 0.08 0.26 <0.001 0.083 
Any maternal marijuana use (%)j 7.97 34.90 48.57 <0.001 0.392 
Maternal average daily volume of 
alcohol j  
0.69 1.19 1.28 <0.001 0.027 
Any maternal alcohol use (%)j 73.09 87.25 81.43 0.002 0.153 
Maternal average daily cigarettesj  8.48 10.13 10.03 0.247 0.005 
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Any maternal cigarette use (%)j 50.83 67.11 74.29 <0.001 0.191 
Any maternal other illicit drug use (%)j 4.65 12.08 15.71 0.001 0.159 
Characteristics at 16 Years 
Parental acceptance/involvement scorek 30.19 30.30 30.07 0.936 <0.001 
Parental psychological autonomy scorek 24.54 23.72 23.72 0.170 0.007 
Parental strictness/supervision scorel 19.00 18.70 18.72 0.717 0.001 
Parental authoritativeness overall scorel 1.50 1.32 1.33 0.138 0.008 
Offspring has peers who use cigarettes 
(%)m 
80.76 76.39 80.88 0.544 0.049 
Offspring has peers who drink alcohol 
(%)n 
79.45 79.02 79.41 0.994 0.005 
Offspring has peers who smoke 
marijuana (%)o 
72.41 74.31 85.29 0.088 0.098 
Offspring Characteristics at 22 Years 
Age (mean years) 22.98 22.78 22.70 0.020 0.013 
Race (% African American) 51.59 55.15 79.22 <0.001 0.183 
Education (mean years) 12.82 12.92 12.39 0.056 0.010 
Personal income (mean US$/month) 1006.07 969.70 800.43 0.308 0.006 
Work status (% working or in school) 61.96 63.64 51.95 0.195 0.075 
Marital status (% married) 5.48 7.88 3.90 0.403 0.056 
Lives with mother or caregiver (%) 37.18 30.30 33.77 0.306 0.063 
Has at least one child (%) 36.02 34.55 45.45 0.231 0.071 
Child maltreatment score (mean) 2.35 2.53 2.61 0.072 0.009 
Experienced moderate, severe, or 
extreme child maltreatment (%) 
26.51 30.91 37.66 0.128 0.084 
Family history of alcohol or drug 
problems (%) 
45.38 46.34 54.55 0.341 0.061 
Initiated cigarettes (%) 80.40 83.03 84.42 0.618 0.040 
Past-year cigarette use (%) 41.21 43.64 53.25 0.156 0.080 
Average daily cigarettes 4.00 4.61 5.47 0.138 0.005 
Initiated alcohol (%) 98.85 100.00 98.70 0.372 0.058 
Past-year alcohol use (%) 92.22 93.33 92.21 0.898 0.019 
Average daily volume of alcohol 1.48 1.82 1.59 0.124 0.005 
Initiated marijuana (%) 79.25 87.27 90.91 0.011 0.124 
Past-year marijuana use (%) 44.09 56.97 62.34 0.002 0.147 
Average daily joints of marijuana 0.70 0.67 1.70 <0.001 0.028 
Past-year cocaine use (%) 5.48 7.88 9.09 0.383 0.057 
Past-year other illicit drug use (%) 12.10 14.55 19.48 0.222 0.072 
a Zero joints per day  
b Less than one joint per day 
c One or more joints per day  
d ANOVA for continuous variables, Kruskal-Wallis test for skewed variables, χ2 test for 
dichotomous variables 
e Eta2 for continuous variables, Cramer’s V for dichotomous variables; absolute value reported 
f Sample size: 331, 164, 75 
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g Sample size: 344, 164, 77 
h Sample size: 346, 165, 77 
i Sample size: 297, 149, 68 
j Sample size: 301, 149, 70 
k Sample size: 288, 143, 68
l Sample size: 284, 142, 67 
m Sample size: 291, 144, 68 
n Sample size: 292, 143, 68 
o Sample size: 290, 144, 68
Table 2. First trimester marijuana exposure by offspring frequency of marijuana use at 22 years 
Offspring Frequency of Marijuana Use 
First Trimester Maternal 
Marijuana Use  
No Use 
(n=294) 
Using less than 
three times per 
week 
(n=173) 
Using three 
times per week 
or more 
(n=122) p-valued 
Effect 
sizee 
Nonea (n, %) 
Light to moderateb (n, %) 
Heavyc (n, %) 
194 (65.99) 
71 (24.15) 
29 (9.86) 
99 (57.23) 
50 (28.90) 
24 (13.87) 
54 (44.26) 
44 (36.07) 
24 (19.67) 
0.001 0.123 
a Zero joints per day  
b Less than one joint per day 
c One or more joints per day  
d χ2 test   
e Cramer’s V 
Table 1 Continued
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Table 3. Ordinal logistic regression models evaluating the association between prenatal marijuana exposure 
and offspring frequency of marijuana use 
 Model  1  
(McFadden’s R2=0.001) 
Model 2  
(McFadden’s R2=0.033) 
Model 3  
(McFadden’s R2=0.044) 
Variable p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI 
Prenatal marijuana 
exposure 0.003 1.28 1.09-1.51 0.019 1.22 1.03-1.44 0.182 1.13 0.94-1.36 
Prenatal alcohol 
exposure    0.010 1.19 1.04-1.36 0.017 1.18 1.03-1.35 
Offspring race    0.013 0.66 0.48-0.92 0.037 0.70 0.50-0.98 
Offspring gender    0.000 1.91 1.39-2.62 0.000 1.98 1.44-2.73 
Offspring age at 
assessment    0.030 0.77 0.61-0.97 0.028 0.77 0.61-0.97 
Maternal marijuana 
use at 10 years       0.164 1.52 0.84-2.73 
Home environment 
at 10 years       0.313 0.97 0.90-1.03 
Child maltreatment       0.004 1.23 1.07-1.42 
 
Table 4. Ordinal logistic regression models testing moderation of prenatal marijuana exposure and 
offspring frequency of marijuana use 
 Model  4  
(McFadden’s R2=0.045) 
Model 5  
(McFadden’s R2=0.044) 
Model 6  
(McFadden’s R2=0.050) 
Variable p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI 
Prenatal marijuana 
exposure 0.679 1.05 0.84-1.31 0.388 1.09 0.89-1.34 0.002 1.95 1.28-2.97 
Prenatal alcohol 
exposure 0.017 1.18 1.03-1.35 0.020 1.17 1.03-1.35 0.039 1.15 1.01-1.32 
Offspring race 0.039 0.70 0.50-0.98 0.025 0.66 0.46-0.95 0.046 0.71 0.51-0.99 
Offspring gender 0.001 1.83 1.30-2.58 0.000 1.99 1.45-2.73 0.000 2.03 1.47-2.79 
Offspring age at 
assessment 0.026 0.77 0.60-0.97 0.032 0.77 0.61-0.98 0.025 0.76 0.60-0.97 
Maternal marijuana 
use at 10 years 0.221 1.45 0.80-2.63 0.148 1.54 0.86-2.77 0.216 1.45 0.80-2.62 
Home environment 
at 10 years 0.322 0.97 0.90-1.03 0.306 0.97 0.90-1.03 0.359 0.97 0.91-1.04 
Child maltreatment 0.005 1.23 1.07-1.42 0.005 1.23 1.07-1.42 0.000 1.34 1.15-1.57 
PME x gender 0.228 1.25 0.87-1.81       
PME x race    0.404 1.21 0.78-1.87    
PME x child 
maltreatment       0.004 0.85 0.75-0.95 
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Figure 1. Maternal marijuana use by trimester 
 
 
Figure 2. Predicted probability of offspring frequency of marijuana use 
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3.1 ABSTRACT 
Background. Prenatal marijuana exposure (PME) affects the development of the CNS of the 
fetus. Prior studies demonstrate that PME predicts offspring behavior in childhood and marijuana 
initiation and frequency of use in adolescence. The aim of this study was to evaluate pathways 
from PME to frequency of offspring marijuana use in young adulthood through offspring 
behavior and the age of marijuana initiation.  
Methods. Path analyses were conducted to examine potential pathways from PME to 
offspring frequency of marijuana use at 22 years of age. Women were recruited from a prenatal 
clinic in Pittsburgh, Pennsylvania from 1982-1985 when they were in their fourth month of 
pregnancy. At 22 years, offspring marijuana use was defined as no use, use <3 times per week, 
and use ≥3 times per week. Analyses were performed on 585 mother-offspring pairs, 
representing 77% of the birth cohort. We tested the significance of the indirect paths from PME 
to young adult offspring marijuana use through offspring depressive symptoms, anxiety, 
attention, delinquent behavior at 10 years of age, and parental authoritativeness at age 16, as well 
as early initiation of marijuana use. Early initiation of marijuana was defined as never used, first 
use ≥16 years, or first use <16 years;  
Results. There was not a significant direct relationship between PME and offspring 
frequency of marijuana use in young adulthood after adjusting for prenatal alcohol exposure, the 
home environment, maternal marijuana use when the offspring were 10 years of age, and 
offspring age, gender, race, and history of childhood maltreatment. However, there was a 
significant indirect path between PME and offspring frequency of use through early initiation of 
marijuana (p=0.025). There was a significant indirect path of PME on offspring frequency of use 
through depressive symptoms and early initiation of marijuana (p=0.043). PME predicted 
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initiation of marijuana use, although maternal marijuana use when the offspring were 10 years of 
age did not predict initiation. We did not find significant indirect pathways from PME to 
offspring frequency of marijuana use through offspring anxiety, attention, and delinquent 
behavior at age 10 or parental authoritativeness at age 16.  
Conclusions. PME had an indirect effect on offspring frequency of marijuana use in 
young adulthood. These findings demonstrate that PME in conjunction with early age of 
initiation and depression create a vulnerability to marijuana use in offspring.  The implications of 
this research are that there are several time points for public health intervention:  women should 
be counseled to abstain from using marijuana during pregnancy, healthcare providers should 
screen for depressive symptoms in children, and public health efforts should focus on programs 
to delay the initiation of marijuana among youth.  
3.2 INTRODUCTION 
Marijuana is the most widely-used illicit substance in the world (Danovitch & Gorelick, 2012). 
The United Nations Office on Drugs and Crime (UNODC) estimates that the annual prevalence 
of use may be as high as 5% (United Nations Office on Drugs and Crime, 2012). Marijuana use 
typically begins in adolescence and peaks in young adulthood (Copeland, Rooke, & Swift, 
2013). In the US, the average age of marijuana initiation is 17.5 years (Substance Abuse and 
Mental Health Services Administration [SAMSHA], 2012). Males have higher rates of use than 
females, but this gender gap may be narrowing (Perkonigg et al., 2008; von Sydow et al., 2001; 
SAMSHA, 2012; Wallace et al., 2003). In addition, national survey data of middle and high 
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school students indicate that use is highest among Native Americans, followed by Hispanics, 
whites, blacks, and Asian-Americans (Wallace et al., 2003).  
Other influences also play a role in marijuana initiation and use. The effects of genetics 
on marijuana use have been demonstrated using twin studies (Agrawal & Lynskey, 2006) and 
family histories of substance use problems (Agrawal & Lynskey, 2006; von Sydow, Lieb, 
Pfister, Hofler, & Wittchen, 2002). Environmental factors include leaving the family home 
before the age of 18, family conflict, change in mother’s marital status, maternal smoking and 
marijuana use when the offspring was an adolescent, parental supervision and control, and peer 
marijuana use (Day, Goldschmidt, & Thomas, 2006; M. R. Hayatbakhsh et al., 2008; M. R. 
Hayatbakhsh, Najman, Bor, O'Callaghan, & Williams, 2009; Perkonigg et al., 2008; Richardson, 
Larkby, Goldschmidt, & Day, 2013; von Sydow et al., 2002). Psychosocial factors include 
having an antisocial personality diagnosis, low self-competence, distressing life events, having a 
high number of symptoms of depression and anxiety, aggressive and delinquent behavior, and a 
history of childhood maltreatment, particularly sexual and physical abuse (Day et al., 1994; M. 
R. Hayatbakhsh et al., 2009; Kilpatrick et al., 2000; Lo & Cheng, 2007; Perkonigg et al., 2008). 
One understudied factor is whether prenatal marijuana exposure (PME) is associated with 
offspring marijuana use. Marijuana is a commonly-used illicit substance during pregnancy. 
Findings from the National Pregnancy and Health Survey conducted in 1992-1993 demonstrate 
that 2.9% of women used marijuana at some point during pregnancy (National Institute on Drug 
Abuse [NIDA], 1996). When marijuana is consumed, delta-9-tetrahydrocannabinol (THC), the 
main psychoactive ingredient, enters the mother’s bloodstream and crosses the placenta 
(Sundram, 2006). These exogenous cannabinoids bind to receptors in the developing ECS, which 
is important in progenitor cell migration and differentiation, neuronal migration, development of 
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axonal pathways, and the creation of functional synapses (Gaffuri, Ladarre, & Lenkei, 2012; Wu, 
Jew, & Lu, 2011). Animal models also demonstrate that PME affects the endogenous opioid, 
dopamine, and serotonin systems, which puts offspring at risk for problems with emotion 
regulation, memory, depression, and addiction later in life (Jutras-Aswad, DiNieri, Harkany, & 
Hurd, 2009). 
Two birth cohorts have published findings on long-term behavioral outcomes of PME: 
the Maternal Health Practices and Child Development (MHPCD) study and the Ottawa Prenatal 
Prospective Study (OPPS).  PME predicted deficits in memory and attention, increases in 
impulsivity and hyperactivity, symptoms of anxiety and depression, delinquent behavior, age of 
initiation of marijuana, and offspring frequency of marijuana use in adolescence (Day et al., 
2006; Day, Leech, & Goldschmidt, 2011; Day et al., 1994; Fried & Watkinson, 1990; Fried, 
Watkinson, & Gray, 1992; Goldschmidt, Day, & Richardson, 2000; Goldschmidt, Richardson, 
Cornelius, & Day, 2004; Gray, Day, Leech, & Richardson, 2005; Leech, Richardson, 
Goldschmidt, & Day, 1999; Porath & Fried, 2005). All of these consequences of PME are also 
associated with marijuana use and serve as the rationale for our path analysis. 
To date, no published findings exist on pathways from PME to offspring frequency of 
marijuana use in young adulthood. In this paper, we conducted path analyses to evaluate 
significant direct and indirect pathways to offspring frequency of marijuana use through 
offspring behavior. We hypothesized that: 1) PME would predict offspring frequency of 
marijuana use at 22 years, 2) PME would predict offspring depressive symptoms, anxiety, 
attention, and delinquent behavior at 10 years of age, early initiation of marijuana, and parental 
authoritativeness at age 16, 3) offspring depressive symptoms, anxiety, attention, and delinquent 
behavior at 10 years of age and parental authoritativeness at age 16 would predict early initiation 
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of marijuana, and 4) depressive symptoms, anxiety, attention, and delinquent behavior at 10 
years of age, early initiation of marijuana, and parental authoritativeness at age 16 would predict 
offspring frequency of use at 22 years. 
3.3 METHODS 
3.3.1 Sample description 
The data for this study come from the MHPCD study at the University of Pittsburgh. This is a 
longitudinal study evaluating the effects of prenatal exposure to alcohol and marijuana on 
offspring development. Study participants were recruited from a prenatal clinic at Magee 
Women’s Hospital in Pittsburgh, PA from 1982-1985. To be eligible, participants had to speak 
English, be at least 18 years of age, and in their fourth or fifth gestational month. There was a 
15% refusal rate. An initial interview about substance use (alcohol, tobacco, marijuana, and other 
illicit drugs) in the first trimester was completed by 1,360 women.  
This initial interview was used to select two cohorts. One cohort was composed of 
women who drank three or more alcoholic drinks per week in the first trimester and a random 
sample of one-third of those women who drank less than this amount or not at all. The second 
cohort was composed of women who used marijuana at least two times per month in the first 
trimester and a random sample of one-third of those women who reported they used less 
marijuana or none at all. Sampling was done with replacement allowing women to eligible for 
both cohorts. Both studies had the same protocols and personnel, allowing the cohorts to be 
combined for analyses. The combined cohort was 829 women and there was 60% overlap 
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between the cohorts. This study was approved by the Institutional Review Board of the 
University of Pittsburgh and Magee-Womens Hospital, and informed consent was obtained from 
the women at each phase.   
The women enrolled in the MHPCD study were interviewed again in their 7th gestational 
month. Subsequent assessments of mothers and offspring were conducted after the offspring’s 
birth, 8 and 18 months, and 3, 6, 10, 14, 16, and 22 years of age. At each phase of data 
collection, information was gathered about maternal psychological, social, and environmental 
factors, demographic status, and substance use, and the children's cognitive, behavioral, 
psychological, and physical development. 
The birth cohort consisted of 763 live singleton infants. Eight individuals refused the 
delivery assessment, 16 women were lost to follow-up, and 21 women moved out of the area. 
Other exclusions included 18 offspring due to fetal or perinatal death, one infant was placed for 
adoption and could not be followed, and two sets of twins. Only mother-child pairs who 
completed the assessment at birth were selected for follow-up. 
 At the 22-year phase, 608 offspring participated in an interview, 80% of the birth cohort. 
Among those 155 who did not participate, 30 individuals refused, 3 had been adopted, 18 were 
institutionalized, 56 were lost to follow up, 29 had moved out of the area, 11 had died, and 8 
could not participate due to low cognitive functioning. Twenty-three individuals were excluded 
from the analyses: 14 did not complete the instrument about child maltreatment used in this 
analysis, five reported that they did not use marijuana but had positive results on a urine screen, 
and four initiated marijuana prior to the assessment of depressive symptoms at age 10. The final 
sample size was 585 individuals representing 77% of the birth cohort. Those who were included 
in the analyses (n=585) did not differ from those who were excluded from the analyses (n=178) 
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based on characteristics assessed at the first trimester visit. There were no differences by age, 
race, education, marital status, household income, and substance use (Appendix, Table 13). 
3.3.2 Measures 
3.3.2.1 Prenatal marijuana exposure 
The mothers provided information about the pattern of their marijuana use at each assessment. A 
series of questions developed for the MHPCD study measured usual, maximum, and minimum 
quantity and frequency (Day & Robles, 1989). The same questions were asked about use of 
hashish and sinsemilla. Conversions of hashish and sinsemilla were done to account for the 
higher THC content in those substances. One joint of sinsemilla was equal to two joints of 
marijuana, one joint or bowl of hashish was equal to three joints of marijuana (Gold, 1989; 
Hawks, 1986; Julien, 1988). A blunt was scored as the self-reported number of joints in the 
blunt. If the participant did not report the number of joints in the blunt, then it was coded as four 
joints. Marijuana use was calculated as the average daily joints (ADJ). The ADJ formula is: 
(number of joints/week x 4 weeks/month)/31 days/month. An ADJ of 0.4 is equivalent to using 
three joints per week and an ADJ of 0.89 is equivalent to using one joint per day. A bogus 
pipeline was used to encourage accurate reporting of substance use at the first phase (Jones & 
Sigall, 1979). 
3.3.2.2 Offspring frequency of marijuana use 
Marijuana use among the offspring was measured with the same questions and conversions 
described above. The frequency categories were collapsed to no use, use <3 times per week, and 
use ≥3 times per week to be consistent with a prior analysis using this data set (Day et al., 2006).  
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3.3.2.3 Intervening variables and covariates 
The variables considered for the analyses were based on a review of the literature and prior 
experience with this data set. The intervening variables were: offspring depressive symptoms, 
anxiety, attention, and delinquent behavior at age 10; early initiation of marijuana; and parenting 
at age 16.  
At 10 years of age, the offspring completed the Children’s Depression Inventory (CDI; 
Kovacs, 1992) that asks children about depressive symptoms experienced during the past two 
weeks. The instrument has 27 questions in which a 0 indicates not experiencing a symptom, a 1 
indicates experiencing a mild symptom, and a 2 indicates experiencing the symptom. The 
responses were totaled and a continuous T-score was used in the analyses. Depressive symptoms 
at this phase were chosen for this analysis because PME predicted depressive symptoms at age 
10 in this cohort and this assessment occurred before the majority of offspring initiated 
marijuana (Gray et al., 2005). 
The Revised Children’s Manifest Anxiety Scale (RCMAS; Reynolds & Richmond, 1978) 
was used to assess offspring anxiety. This 28-item questionnaire assesses anxiety on subscales of 
physiological anxiety, worry/oversensitivity, and fear/concentration. The total score is the sum of 
the offspring’s affirmative responses.  
Offspring attention was assessed using the Swanson, Noland, and Pelham (SNAP; 
Pelham & Bender, 1982) questionnaire. The SNAP is made up of 25 questions that correspond 
with the Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-3) 
definition of Attention Deficit Disorder with Hyperactivity. The responses of never, sometimes, 
often, and all the time are reported on a Likert scale ranging from 1-4. We used the attention 
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subscale in the analyses, which is the sum of four questions. The SNAP questionnaire was 
completed by the mothers. 
Offspring delinquent behavior was assessed using the Child Behavior Checklist (CBCL; 
Achenbach; 1991). The mothers completed 113 questions about the offspring’s behavior at 10 
years. The responses are summed to create scores for total problems, internalizing problems, 
externalizing problems, and eight subscales. The delinquent behavior subscale T-score was used 
in these analyses.  
At the 10-year assessment, the offspring were asked to report whether they had used 
alcohol or drugs and the age at which they first tried each substance (Jessor, Donovan, & Costa, 
1989). These questions were also asked at the 14, 16, and 22-year study visits. Where there were 
differences, the youngest reported age of initiation was used in these analyses. Early initiation 
was defined at use <16 years of age. A categorical variable was created: never used marijuana, 
first use ≥16 years, or first use <16 years. The age used to define early initiation of substances 
varies in the literature (R. Hayatbakhsh, Williams, Bor, & Najman, 2013; Kokkevi, Nic 
Gabhainn, Spyropoulou, & Risk Behaviour Focus Group of the HBSC, 2006; Lynskey et al., 
2003). We selected 16 because it is below the average age of marijuana initiation in the US 
(SAMSHA, 2012).   
At 16 years of age, parenting was assessed using the My Parents (Steinberg, Lamborn, 
Dornbusch, & Darling, 1992) tool. The offspring completed this questionnaire and scores were 
ascertained for three subscales related to parental acceptance/involvement, supervision/strictness, 
and psychological autonomy granting. These subscales were used to create a composite of an 
overall score of authoritativeness used for the analyses (Steinberg et al., 1992). A subscale score 
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above the median was coded as a 1, otherwise it was coded as 0. The sum is added for a 
maximum of three.  
The covariates for which we adjusted were first trimester maternal alcohol use, the home 
environment, maternal marijuana use when the offspring were 10 years of age, and the 
offspring’s gender, age, race, and history of childhood maltreatment. We adjusted for maternal 
alcohol use because the analyses were conducted on the combined alcohol and marijuana 
cohorts. We adjusted for the  home environment at age 10 as assessed by the mother’s reports on 
the Home Observation for Measurement of the Environment-Short Form (HOME; Baker & 
Mott, 1989), a measure of the cognitive stimulation and emotional support that the child 
receives. The mothers reported their substance use when their offspring were 10 years of age. 
We chose to use the ADJ at this time point because of its potential influence on offspring use. 
The offspring’s gender was ascertained from the birth assessment and age was calculated from 
the birth date. We adjusted for gender because males have a higher rate of marijuana use and age 
because offspring were 21-26 years old when completing this data collection phase. We also 
adjusted for race because African American mothers were more likely to use marijuana than 
Caucasian mothers in this sample. Lastly, we adjusted for offspring childhood maltreatment, 
which was assessed at 22 years of age using the Child Trauma Questionnaire (CTQ; Bernstein & 
Fink, 1998). The CTQ contains 25 items that assess whether an individual experienced the 
following five types of abuse: emotional abuse, physical abuse, sexual abuse, emotional neglect, 
or physical neglect when they were growing up. Respondents use a 5 point Likert scale ranging 
from never true to very often true. The scores for the subscales range from 5 to 25. The subscales 
were dichotomized to indicate whether an offspring had experienced moderate to severe abuse 
using the following suggested cut points for the five subscales: ≥13 for emotional abuse, ≥10 for 
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physical abuse, ≥8 for sexual abuse, ≥15 for emotional neglect, and ≥10 for physical neglect 
(Bernstein & Fink, 1998). A sum of the five dichotomous scales was used in the analyses. 
3.3.3 Analysis plan 
Analyses were performed on the combined marijuana and alcohol cohorts. We restricted our 
analyses to the first trimester for two reasons. First, approximately 10% of the participants did 
not complete the interview for the second trimester. Second, marijuana use declined during 
pregnancy. While 41% of the sample reported marijuana use during the first trimester, only 18% 
of the sample reported use by the third trimester (Figure 3). Sample sizes in the second and third 
trimesters were not large enough to analyze patterns of exposure. Table 14 of the Appendix 
displays the sample sizes and marijuana use of the mothers across gestation. 
The distributions of marijuana and alcohol variables were examined. Out of range values 
for marijuana were set to 10.0 joints per day and the out of range values for alcohol use were set 
to 8.0 drinks per day.  
Descriptive statistics were generated to explore the associations between variables. We 
looked at the correlations and performed t-tests or analysis of variance (ANOVA) to evaluate 
continuous variables. For those continuous variables that were not normally distributed, we used 
the Mann-Whitney U or the Kruskal-Wallis test. We performed Chi-square tests to evaluate the 
associations between dichotomous variables. Cohen’s d and Cramer’s V were calculated to 
assess effect size.  
Path analyses were performed using Mplus version 5.2 (Muthén & Muthén, 2008). The 
mean and variance adjusted weighted least square (WLSMV) adjusted estimation method was 
used due to the categorical dependent variables in this analysis. The fit of the path model was 
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assessed using several indices. A value over 0.95 is considered good for the comparative fit 
index (CFI; Hu & Bentler, 1999). For the Tucker-Lewis Index (TLI), over .90 is considered a 
good fit, the Root Mean Square Error of Approximation (RMSEA) value of less than .06 is 
considered a good fit, and a Weighted Root Mean Square Residual (WRMR) of less than .90 is 
considered a good fit (Hu & Bentler, 1999; Yu, 2002).  
3.4 RESULTS 
Table 15 of the Appendix displays characteristics of the sample. At the first trimester visit, the 
average age of the mothers was 23 years (range: 18-42), 52% were African American, and 32% 
were married. The women had completed 11.8 years of education, 26% were in school or worked 
outside the home, and 61% had a household monthly income of less than $400. Sixty-four 
percent used alcohol, 41% used marijuana, 53% smoked cigarettes, 4% used cocaine, and 9% 
used other illicit drugs. At birth, 47% of the offspring were male. The average gestational age 
was 40 weeks and the average birth weight was 3.2kg. At 10 years of age, the offspring had an 
average CDI T-score of 45.94 (range: 35-77), with a higher score indicating more depressive 
symptoms. The average anxiety score was 10.06 (range: 0-29), the average attention score was 
8.84 (range: 5-20), and the average delinquent behavior CBCL subscale T-score was 55.98 (50-
94). The average parenting score for authoritativeness was 1.43, indicating parenting was 
somewhat nonauthoritative. By age 16, 51% of the offspring had tried marijuana. At the 22-year 
assessment, the average age was 22.8 years and 56% of the offspring were African American. 
They had completed 12.8 years of education and 61% were working and/or in school. The 
median monthly income was $800. Thirty-five percent were living with their mother or a 
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caregiver, 6% were married, and 37% had at least one child. Twenty-nine percent experienced 
moderate, severe, or extreme childhood maltreatment. The average childhood maltreatment score 
was 2.42 (range: 1-5) with a higher score indicating a higher level of childhood maltreatment. In 
the past year, 43% of the offspring used cigarettes, 92% used alcohol, 7% used cocaine, and 14% 
used other illicit drugs. Fifty percent of offspring did not use marijuana, 29% used marijuana <3 
times per week, and 20% used marijuana ≥3 times per week in the past year. 
Table 5 displays sample characteristics by maternal first trimester marijuana use. For 
descriptive purposes, categories were created representing women who did not use marijuana 
during the first trimester, light to moderate users (<1 joint/day), and heavy users (≥1 joint/day). 
As the category of PME increased, there was an increase in the percent of African American 
women, household income less than $400, average daily volume of alcohol, cigarette use, 
cocaine use, and use of other illicit drugs. As the level of PME increased, the percent of women 
who were married decreased. Women with PME in the light to moderate categories had the 
highest percent of women who reported any alcohol use. There were no differences in PME by 
maternal age, years of education completed, or average daily cigarettes smoked. PME was 
associated with maternal marijuana use when the offspring were 10 years of age. The mean ADJ 
increased as PME increased. At birth, offspring did not differ by gender, gestational age, or birth 
weight. At 10 years, offspring depressive symptoms, anxiety, and attention problems increased 
as PME increased. There were no differences by PME in delinquent behavior or the home 
environment at age 10 or parental authoritativeness at age 16. At 22 years, the offspring with 
PME were slightly younger and more likely to be African American. There were no differences 
by years of education completed, whether they were working and/or in school, personal monthly 
income, marital status, living with a mother or caregiver, having at least one child, or history of 
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childhood maltreatment. Those offspring with PME were more likely to initiate marijuana and to 
initiate marijuana early compared to those offspring without PME. The percent of offspring who 
reported any marijuana use in the past year increased as PME increased. There were no 
differences according to past-year use of alcohol, cigarette, cocaine, or other illicit drugs.  
Table 16 of the Appendix displays sample characteristics according to offspring 
frequency of marijuana use at 22 years. There were no differences according to the maternal age, 
education, working outside the home and/or in school, or household income. Offspring who did 
not use marijuana were more likely to have white mothers and those who used were more likely 
to have African American mothers. The percent of mothers who were married at the first 
trimester visit decreased as the offspring frequency of use category increased. There were no 
significant differences by maternal use of alcohol, cigarettes, cocaine, or other illicit drugs. 
Maternal use during the first trimester increased as offspring frequency of use increased. At 
birth, there were no differences by gestational age. Birth weight was inversely proportional to the 
frequency of marijuana use. The percent of males significantly increased as frequency of 
marijuana use increased. Home environment scores decreased as frequency of offspring 
marijuana use increased, demonstrating lower emotional support and cognitive stimulation 
among those who became frequent marijuana users. Maternal mean ADJ, depressive symptoms, 
anxiety, attention problems, and delinquency scores increased as offspring frequency of 
offspring marijuana use increased. At age 16, there were no differences by parental 
authoritativeness. At 22 years, there were significant demographic differences. As the frequency 
of use increased, the percent of African Americans in each category increased. Younger 
offspring used marijuana at lower rates, and the percent of offspring who were married and 
working and/or in school decreased as offspring frequency of marijuana use increased. Offspring 
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median income also decreased as frequency of marijuana use category increased. Having at least 
one child or living with a mother or caregiver did not differentiate use patterns. There was a 
difference by childhood maltreatment: Nonusers had the lowest average childhood maltreatment 
scores compared to marijuana users, although those who used at a higher rate (<3x per week) 
reported more childhood maltreatment compared to heavier users. Marijuana initiation differed 
according to offspring frequency of use. Those using most frequently were more likely to initiate 
marijuana before age 16. Marijuana users were also more likely to report using alcohol, 
cigarettes, cocaine, and other illicit drugs. 
Path analyses were used to test our hypotheses. First, we fit a model with depressive 
symptoms at age 10 and early initiation of marijuana as the hypothesized intervening variables, 
adjusting for prenatal alcohol exposure, the home environment, maternal marijuana use when the 
offspring were 10 years of age, and offspring age, gender, race, and history of childhood 
maltreatment. Although we hypothesized that PME would have a significant direct effect on 
offspring frequency of marijuana use, the results did not support this hypothesis (p=0.841) 
(Appendix, Table 17, Model 1). In a second model, we removed this path. In model 2, we 
observed that the path from depressive symptoms to offspring frequency of use was non-
significant (p=0.502). We removed this path (Model 3) and observed that the covariate of 
maternal marijuana use at 10 years was not a significant predictor of offspring age of initiation. 
We further evaluated this relationship by using it as an intervening variable instead of a covariate 
(Model 4). The model fit was good. There was no significant difference between the observed 
and model covariance matrices, χ2(3) = 0.969, p = 0.809, CFI = 1.000, TLI = 1.054, RMSEA = 
0.000, WRMR = 0.085. We used this as our base model for adding other intervening variables.  
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We hypothesized that there would be a significant indirect effect from PME to offspring 
frequency of marijuana use through anxiety, attention, and delinquent behavior at age 10 and 
parenting at age 16. We tested the effect of each intervening variable separately. PME did not 
significantly predict anxiety, attention, delinquent behavior, or parenting. There were no 
significant indirect effects and none of these intervening variables are included in our final 
model. Thus, these hypotheses were not supported.  Thus, Model 4 was retained as the final 
model.  
The final results are displayed in Table 6 and Figure 4. PME predicted depressive 
symptoms at age 10 (β = 0.140; p<0.001) as did prenatal alcohol exposure (β = 0.080; p=0.041), 
the home environment score (β = -0.107; p=0.016), and childhood maltreatment (β = 0.158; 
p<0.001). Overall, 9% of the variance of depressive symptoms was explained by PME and the 
covariates. PME also predicted maternal marijuana use at 10 years (β = 0.141; p<0.001). Overall, 
12% of the variance of maternal marijuana use at the 10-year assessment was explained by PME 
and the covariates. 
PME significantly predicted early initiation of marijuana use in the offspring. Offspring 
were 14% more likely to initiate marijuana early for a one standard deviation increase in PME. 
Offspring were 13% more likely to initiate marijuana early for one standard deviation 
increase in depressive symptoms. Male offspring were 15% more likely to initiate marijuana 
earlier than females. Twelve percent of the variance of early initiation of marijuana was 
explained by PME, depressive symptoms, maternal marijuana use at the 10-year assessment, and 
the covariates. Offspring who initiated use earlier were 73% more likely to be in a higher 
frequency of use category. Thirty-eight percent of the variance of offspring frequency of use was 
explained by marijuana initiation and the covariates.  
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Overall, there was a significant indirect effect of PME on offspring frequency of 
marijuana use at age 22 through early initiation of marijuana (p=0.025). There was a significant 
indirect effect of PME on offspring frequency of marijuana use at age 22 through two 
intervening variables, depressive symptoms and early initiation of marijuana (p=0.043).  
3.5 DISCUSSION 
 The aim of this paper was to describe the direct and indirect pathways from PME 
to offspring frequency of marijuana use in young adulthood. Although PME predicted 
offspring frequency of marijuana use at 22 years in bivariate analyses, the association was not 
significant after adjusting for prenatal alcohol exposure, the home environment, maternal 
marijuana use when the offspring were 10 years of age, and the offspring’s age, gender, 
race, and history of childhood maltreatment. We found a significant indirect path from PME 
to offspring frequency of marijuana use through early initiation of marijuana. We found a 
second significant indirect path of PME on offspring frequency of marijuana use through 
depressive symptoms and early initiation of marijuana.  
Although PME predicted offspring marijuana initiation, maternal marijuana use at 10 
years did not, suggesting a biological association between PME and offspring frequency of 
marijuana use rather than an environmental influence. Although PME predicted attention, 
anxiety, and delinquent behavior at age 10 in prior analyses of this dataset, we did not see 
significant paths in our model (Goldschmidt et al., 2000; Goldschmidt et al., 2004). One reason 
may be that we controlled for childhood maltreatment in these analyses but not in earlier ones.  
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This study has several strengths. The study had a large sample size of 585 individuals and 
excellent follow-up rates with 77% of the birth cohort available for this analysis. Second, this 
study recruited approximately equal numbers of African American and Caucasian women, 
allowing a racially heterogeneous sample. Third, the data for this study were obtained 
prospectively, which avoids recall bias. 
There are some limitations of this analysis. This sample is composed of predominately 
low income women, and the results may not be generalizable to women in higher socioeconomic 
groups. Additionally, marijuana use was ascertained by self-report. However, a bogus pipeline 
procedure was used to encourage accurate reporting from mothers at the first prenatal visit. At 
the 22-year visit, a urine screen was part of the study protocol for the offspring. Among those 
who reported they did not use marijuana, only 2% screened positive. Among those who reported 
that they used marijuana in the past year, 64% had positive results on the urine screen. While the 
results of the urine screen can only offer information on recent marijuana use, they do suggest 
that participants are being honest about their use. Further, staff members who interviewed the 
participants were comfortable asking questions about the sensitive topics (e.g., substance use, 
psychosocial factors) and followed an established protocol for the sequence of questioning. In 
addition, a NIH Certificate of Confidentiality allowed us to reassure the participants that their 
data were confidential. 
In summary, this analysis identified significant indirect paths from PME to offspring 
frequency of marijuana use in young adulthood. Marijuana use has health and psychosocial 
consequences. Chronic smoking of marijuana affects the respiratory system (Taylor et al., 2002). 
Marijuana use is associated with an increased risk of schizophrenia symptoms and 9% of users 
become dependent (Andreasson, Allebeck, Engstrom, & Rydberg, 1987; Anthony, Warner, & 
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Kessler, 1994; Arseneault et al., 2002). Other adverse factors associated with marijuana use 
include lower educational achievement and income, unemployment, and risky sexual behavior, 
which can lead to unintended pregnancy or sexually transmitted infections (Fergusson & Boden, 
2008; Staton et al., 1999). In the MHPCD sample, 29% of those using ≥3 times per week had a 
history of a lifetime Cannabis Use Disorder diagnosis compared to 17% of those using <3 times 
per week and 6% of non-users in the past year. The most frequent users in young adulthood had 
a higher rate of licit and illicit substance use, less formal education, were less likely to be 
working and/or in school, were less likely to be married, had a lower personal monthly income, 
and were more likely to be arrested. Thus, the adverse consequences of cannabis use are 
numerous but preventable. 
Our conclusions offer several time points for public health intervention. First, pregnancy 
is a time of frequent contact with a healthcare provider and pregnant women should be 
encouraged to abstain from using marijuana. Second, healthcare providers could screen for 
depressive symptoms in children. Third, public health could focus interventions to delay 
marijuana initiation because it is a strong predictor of marijuana use in young adulthood. 
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3.7 TABLES AND FIGURES 
Table 5. Sample characteristics by category of first trimester marijuana use 
 Maternal Marijuana Use 
 
No usea 
(n=344) 
Light to 
moderate 
useb 
(n=164) 
Heavy 
usec 
(n=77) p-valued 
Effect 
sizee 
Maternal Characteristics at the First Trimester 
Age (mean years) 23.34 22.62 22.84 0.151 0.007 
Race (% African American)  45.64 53.05 75.32 <0.001 0.196 
Marital status (% married) 37.21 27.44 18.18 0.002 0.147 
Education (mean years) 11.87 11.84 11.73 0.700 0.001 
Employment status (% working outside 
the home and/or in school) 
25.58 31.10 14.29 0.021 0.115 
Household income (%<US$400/month)f 57.01 64.42 73.33 0.020 0.117 
Alcohol use (%) 55.23 78.05 74.03 <0.001 0.222 
Average daily volume of alcohol 0.40 0.75 0.78 <0.001 0.027 
Cigarette use (%) 47.09 60.37 64.94 0.002 0.148 
Average daily cigarettes 7.58 8.70 9.38 0.339 0.004 
Cocaine use (%) 1.74 5.49 9.09 0.004 0.139 
Other illicit drug use (%) 6.98 9.76 15.58 0.051 0.101 
Offspring Characteristics at Birth 
Gender (% male) 47.38 47.56 44.16 0.856 0.022 
Gestational age (mean weeks) 39.70 39.96 39.84 0.403 0.003 
Birth weight (mean kg) 3.21 3.22 3.08 0.183 0.006 
Characteristics at 10 Years 
Home environmentg (mean score) 12.88 12.50 12.37 0.200 0.006 
Depressive symptomsh (mean score) 45.25 45.82 49.04 0.003 0.023 
Anxiety symptomsi (mean score) 9.65 10.15 11.65 0.033 0.012 
Attentionj (mean score) 8.58 8.97 9.70 0.004 0.017 
Delinquent behaviorj (mean score) 55.54 56.18 57.45 0.173 0.008 
Maternal average daily jointsk 0.02 0.07 0.26 <0.001 0.083 
Characteristics at 16 Years      
Parental authoritativeness overall scorel 1.50 1.33 1.33 0.137 0.008 
Offspring Characteristics at 22 Years 
Age (mean years) 22.90 22.78 22.70 0.030 0.012 
Race (% African American) 51.74 55.49 79.22 <0.001 0.182 
Education (mean years) 12.82 12.91 12.39 0.058 0.010 
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Work status (% working and/or in 
school) 
62.21 64.02 51.95 0.176 0.077 
Median personal income (US$/month)m 1006 972 803 0.291 0.006 
Marital status (% married) 5.23 7.93 3.90 0.356 0.059 
Lives with mother or caregiver (%) 37.21 30.49 33.77 0.324 0.062 
Has at least one child (%) 35.76 34.76 45.45 0.230 0.071 
Child maltreatment (mean score) 2.34 2.51 2.61 0.144 0.009 
Past-year cigarette use (%) 40.70 43.29 53.25 0.132 0.083 
Average daily cigarettes  3.94 4.61 5.47 0.186 0.006 
Past-year alcohol use (%) 92.15 93.29 92.21 0.897 0.019 
Average daily volume of alcohol  1.48 1.83 1.59 0.102 0.005 
Marijuana initiation (%) 
     >16 years 
     ≥16 years 
     Never 
 
47.67 
31.40 
20.93 
 
51.22 
35.98 
12.80 
 
62.34 
28.57 
9.09 
0.022 0.099 
Past-year marijuana use (%) 43.60 56.71 62.34 0.001 0.151 
Average daily joints of marijuana 0.69 0.68 1.70 <0.001 0.028 
Frequency of marijuana use (%) 
    No use 
    Use <3 times per week 
    Use ≥3 times per week 
 
56.40 
28.49 
15.12 
 
43.29 
30.49 
26.22 
 
37.66 
31.17 
31.17 
0.001 0.126 
Past-year cocaine use in past year (%) 5.52 7.93 9.09 0.393 0.057 
Past-year other illicit drug use (%) 11.63 14.63 19.48 0.168 0.078 
a Zero joints per day  
b Less than one joint per day 
c One or more joints per day  
d ANOVA for continuous variables, Kruskal-Wallis test for skewed variables, χ2 test for 
dichotomous variables 
e Eta2 for continuous variables, Cramer’s V for dichotomous variables; absolute value reported 
f Sample size: 328, 163, 75 
g Sample size: 294, 148, 68 
h Sample size: 294, 146, 70 
i Sample size: 293, 147, 69 
j Sample size: 298, 148, 69 
k Sample size: 298, 148, 70 
l Sample size: 282, 141, 67 
m Sample size: 336, 159, 75 
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Table 6. Path results for final model 
 B β z p R2 
Depressive Symptoms  PME     0.092 
     Prenatal marijuana exposure 1.256 0.140 3.535 <0.001  
     Prenatal alcohol exposure 0.618 0.080 2.048 0.041  
     Offspring gender -1.407 -0.084 -1.958 0.050  
     Offspring age -0.158 -0.013 -0.290 0.772  
     Offspring race -0.016 -0.001 -0.020 0.984  
     Home environment  -0.334 -0.107 -2.403 0.016  
     Childhood maltreatment 1.224 0.158 3.638 <0.001  
Maternal Use  PME     0.116 
     Prenatal marijuana exposure 0.096 0.319 14.977 <0.001  
     Prenatal alcohol exposure -0.002 -0.007 -0.145 0.884  
     Offspring gender 0.008 0.015 0.364 0.716  
     Offspring age 0.003 0.007 0.284 0.776  
     Offspring race -0.028 -0.050 -0.617 0.537  
     Home environment  -0.008 -0.075 -1.778 0.075  
     Childhood maltreatment -0.016 -0.062 -1.382 0.167  
Early Initiation  PME, Depressive Symptoms, 
and Maternal Use 
    0.122 
     Prenatal marijuana exposure 0.156 0.135 2.651 0.021  
     Depressive symptoms 0.016 0.125  2.651  0.008  
     Maternal use 0.079 0.021 0.391 0.696  
     Prenatal alcohol exposure 0.071 0.072 1.416 0.157  
     Offspring gender 0.298 0.139 3.028 0.002  
     Offspring age -0.162 -0.106 -2.380 0.017  
     Offspring race 0.207 0.096 1.928 0.054  
     Home environment  -0.040 -0.102 -1.928 0.054  
     Childhood maltreatment 0.118 0.120 2.398 0.016  
Offspring Use  Early Initiation     0.382 
     Early initiation 0.655 0.550 8.665 <0.001  
     Prenatal alcohol exposure 0.075 0.063 1.246 0.213  
     Offspring gender 0.317 0.124 2.888 0.004  
     Offspring age -0.088 -0.049 -1.147 0.251  
     Offspring race -0.418 -0.163 -3.413 0.001  
     Home environment  -0.010 -0.022 -0.422 0.673  
     Childhood maltreatment 0.040 0.034 0.694 0.488  
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Figure 3.  Maternal marijuana use by trimester 
 
 
Figure 4. Final path model 
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4.1 ABSTRACT 
Background. Prenatal marijuana exposure (PME) affects the CNS of the developing offspring, 
changing behavior, emotional status, and cognition.  Prior studies have demonstrated that PME 
predicts offspring depressive symptoms, initiation of marijuana, and frequency of marijuana use. 
No published findings have evaluated pathways from PME to Cannabis Use Disorder (CUD) 
diagnosis in offspring. In this paper, we will evaluate whether PME predicts CUD, and whether 
offspring depressive symptoms and early initiation of marijuana are in the pathway from PME to 
CUD diagnosis in young adulthood. 
Methods. A path analysis was conducted to examine potential pathways from PME to 
CUD in offspring at 22 years of age. Women were recruited from a prenatal clinic in Pittsburgh, 
Pennsylvania from 1982-1985 when they were in their fourth month of pregnancy. At 22 years, 
the offspring completed the Diagnostic Interview Schedule-IV (DIS-IV). Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria were used to 
determine a diagnosis of cannabis abuse or dependence. Analyses were performed on 590 
mother-offspring pairs, representing 77% of the birth cohort. Using structural equation modeling, 
we tested the significance of the indirect paths of PME to CUD through offspring depressive 
symptoms at age 10 and early initiation of marijuana, defined as first use before age 16, first use 
after age 16, or never used marijuana.  
Results. At 22 years of age, 80 offspring (14%) had a CUD diagnosis. While there was 
not a significant pathway from PME to CUD after adjusting for prenatal alcohol exposure and 
the offspring’s age, gender, and race, there was a significant indirect path from PME to CUD 
through early initiation of marijuana (p=0.013). There was also a significant indirect path of 
PME to CUD through depressive symptoms and early initiation of marijuana (p=0.023).  
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Conclusions. Although PME did not directly predict CUD, it was associated with a 
significant indirect pathway through depressive symptoms and early initiation of marijuana to 
CUD. The implications of this research are that there are several time points for public health 
intervention prior to the development of CUD:  women should be counseled to abstain from 
using marijuana during pregnancy, healthcare providers should screen for depressive symptoms 
in children, and public health efforts should focus on programs to delay the initiation of 
marijuana among youth.  
4.2 INTRODUCTION 
Marijuana is the most widely-used illicit substance in the world (Danovitch & Gorelick, 2012). 
The United Nations Office on Drugs and Crime (UNODC) estimates that the annual prevalence 
of use may be as high as 5% (United Nations Office on Drugs and Crime, 2012). Marijuana is 
typically initiated in adolescence and used most often until young adulthood (Copeland, Rooke, 
& Swift, 2013).  
Cannabis use disorder (CUD) is a diagnosis of cannabis dependence or cannabis abuse 
defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV; 
APA, 2000). US national survey data demonstrate that the lifetime prevalence of CUD in the US 
is 8.5% (Stinson, Ruan, Pickering, & Grant, 2006). Further, CUD is often a co-morbid 
psychopathological condition. Those with a CUD diagnosis are also likely to have a diagnosis of 
an alcohol use disorder, mood disorder, anxiety disorder, or personality disorder (Stinson et al., 
2006).  
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Prior research has identified demographic and risk factors for CUD. Demographic factors 
include male gender, African American race, and age, as those affected are often adolescents or 
young adults (Compton, Grant, Colliver, Glantz, & Stinson, 2004; Pacek, Malcolm, & Martins, 
2012). Risk factors identified in the literature include family history and genetic heritability of 
CUD, aggressive or delinquent behavior, symptoms of depression and anxiety, exposure to 
violence, use of other licit or illicit substances, early initiation of cannabis use, and a history of 
sexual abuse in childhood (Agrawal & Lynskey, 2006; Brook, Lee, Finch, Koppel, & Brook, 
2011; Chen, O'Brien, & Anthony, 2005; M. R. Hayatbakhsh, Najman, Bor, O'Callaghan, & 
Williams, 2009; von Sydow, Lieb, Pfister, Hofler, & Wittchen, 2002).  
No study has considered the effects of prenatal marijuana exposure (PME). When 
marijuana is consumed by a pregnant woman, the main psychoactive ingredient, delta-9-
tetrahydrocannabinol (THC), enters her bloodstream and crosses the placenta (Sundram, 2006). 
These exogenous cannabinoids bind to receptors in the developing ECS, which has an important 
role in progenitor cell migration and differentiation, neuronal migration, development of axonal 
pathways, and the creation of functional synapses in the CNS (Gaffuri, Ladarre, & Lenkei, 2012; 
C. S. Wu, Jew, & Lu, 2011). Animal models also demonstrate that PME can affect the 
endogenous opioid, dopamine, and serotonin systems (Jutras-Aswad, DiNieri, Harkany, & Hurd, 
2009). These changes put offspring at risk for problems with emotion regulation, memory, 
depression, and addiction later in life.  
Two birth cohort studies have evaluated the long-term effects of PME in human 
populations: the Maternal Health Practices and Child Development (MHPCD) study and the 
Ottawa Prenatal Prospective Study (OPPS). In the MHPCD study, PME predicted depressive 
symptoms in offspring as well as age of marijuana initiation (HR=1.14) and frequency of 
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marijuana use (OR=1.30) at age 14 (Day, Goldschmidt, & Thomas, 2006; Gray, Day, Leech, & 
Richardson, 2005). In the OPPS cohort, PME predicted age of marijuana initiation (OR=2.76, 
95% CI: 1.11-6.86) but not frequency of marijuana use between ages 16-21 (OR=0.79, 95% CI: 
0.33-1.90) (Porath & Fried, 2005).  
By young adulthood, initiation of marijuana has largely occurred and marijuana use is 
most frequent. To date, there have been no findings published on pathways from PME to 
offspring diagnosis of CUD in young adulthood. In this paper, we identified the direct and 
indirect effects of PME on offspring CUD diagnosis at 22 years of age. We hypothesized that: 1) 
PME predicts CUD, 2) depressive symptoms at age 10 predict a CUD diagnosis at age 22, 3) 
PME predicts depressive symptoms at age 10, 4) PME predicts early initiation of marijuana, 5) 
depressive symptoms at age 10 predict early initiation of marijuana, and 6) early initiation of 
marijuana predicts a CUD diagnosis at age 22. 
4.3 METHODS 
4.3.1 Sample description 
The data for this study come from the MHPCD study at the University of Pittsburgh. This is a 
longitudinal study designed to evaluate the effects of prenatal exposure to alcohol and marijuana 
on offspring development. Participants were recruited from a prenatal clinic at Magee-Womens 
Hospital in Pittsburgh, PA. The recruitment took place from 1982-1985. To be eligible, 
participants had to speak English, be at least 18 years of age, and in their fourth or fifth 
gestational month. The refusal rate was 15%. There were 1,360 women who completed an initial 
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interview about substance use in the first trimester. These substances were alcohol, tobacco, 
marijuana, cocaine, and other illicit drugs.  
The initial interview was conducted to select two cohorts. One cohort was composed of 
women who drank three or more alcoholic drinks per week in the first trimester and a random 
sample of one-third of those women who drank less than this amount or not at all. The second 
cohort was composed of women who used marijuana at least two times per month in the first 
trimester and a random sample of one-third of those women who reported they used less 
marijuana or none at all. Sampling was done with replacement allowing women to be eligible for 
both cohorts. All participants followed the same protocols, which allowed the cohorts to be 
combined for analyses. The combined cohort was composed of 829 women with 60% overlap. 
Informed consent was obtained from the women and this study was approved by the Institutional 
Review Boards of the University of Pittsburgh and Magee-Womens Hospital. 
The women in the MHPCD cohorts were interviewed again in their 7th gestational month. 
Subsequent assessments of mothers and offspring were conducted after the offspring’s birth, 8 
and 18 months, and 3, 6, 10, 14, 16, and 22 years of age. At each phase of data collection, 
information was gathered about maternal psychological, social, and environmental factors, 
demographic status, and substance use, and the children's cognitive, behavioral, psychological, 
and physical development. 
The birth cohort consisted of 763 live singleton infants. Eight individuals refused the 
delivery assessment, 16 women were lost to follow-up, and 21 women moved out of the area. 
Other exclusions included 18 offspring due to fetal or perinatal death, one child who was placed 
for adoption and could not be followed, and two sets of twins. Only those mother-child pairs who 
completed the assessment at birth were followed-up. 
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 At the 22-year phase, 608 offspring participated in an interview, representing 80% of the 
birth cohort. Among those 155 individuals who did not participate, 30 refused the assessment, 3 
had been adopted and could not be followed, 18 were institutionalized in jail or a rehabilitation 
facility, 56 were lost to follow-up, 29 had moved out of the area, 11 died, and 8 could not 
participate due to low cognitive functioning. Eighteen individuals were excluded for the 
purposes of this analysis: 14 did not complete the instrument used to assess CUD and four 
initiated marijuana prior to the assessment of depressive symptoms at age 10. The final sample 
size was 590 offspring, representing 77% of the birth cohort. Those included in the analysis 
(n=590) did not differ from those excluded from the analysis (n=173) based on maternal age, 
race, education, marital status, household income, and substance use assessed at the first 
trimester interview (Appendix, Table 18).   
4.3.2 Measures 
4.3.2.1 Prenatal marijuana exposure 
The mothers provided information about their patterns of marijuana use at each assessment. A 
series of questions developed for the MHPCD study was administered to assess usual, maximum, 
and minimum use and quantity (Day & Robles, 1989). The same questions were asked to 
ascertain use of hashish and sinsemilla. Conversions of hashish and sinsemilla amounts were 
done to account for the higher THC content in those substances. One joint of sinsemilla was 
equal to two joints of marijuana, one joint or bowl of hashish was equal to three joints of 
marijuana (Gold, 1989; Hawks, 1986; Julien, 1988). A blunt was scored as the self-reported 
number of joints in the blunt. If the participant did not report the number of joints in the blunt, 
then it was coded as four joints. Marijuana use was calculated as the average daily joints (ADJ). 
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The ADJ formula is: (number of joints/week x 4 weeks/month)/31 days/month. An ADJ of 0.4 is 
equivalent to using three joints per week and an ADJ of 0.89 is equivalent to using one joint per 
day. A bogus pipeline procedure was used initially to encourage accurate reporting of substance 
use (Jones & Sigall, 1971). 
4.3.2.2 Cannabis Use Disorder 
At the 22-year assessment, the offspring completed the Diagnostic Interview Schedule-IV (DIS-
IV; Robins, et al., 1994). The DIS-IV is a structured interview that can be administered by non-
clinicians. The DIS-IV aligns with the criteria of the DSM-IV (APA, 2000). Current (past 12 
months) and lifetime diagnoses of cannabis abuse and dependence were assessed. The interviews 
were audiotaped and a trained clinician listened to a random sample of de-identified tapes to 
ensure the study protocol was followed. If a deviation from protocol was observed, then staff 
members received additional training. 
4.3.2.3 Intervening variables and covariates 
The variables considered for these analyses were based on a review of the literature and prior 
experience with this data set. At 10 years of age, the offspring completed the Children’s 
Depression Inventory (CDI; Kovacs, 1992), which asks children to report depressive symptoms 
experienced during the past two weeks. The offspring completed 27 questions in which a 0 
indicates not experiencing a symptom, a 1 indicates experiencing a mild symptom, and a 2 
indicates experiencing the symptom. The responses were totaled and a continuous T-score was 
used in the analyses. Depressive symptoms at this phase were used because PME predicted 
depressive symptoms at age 10 in the cohort and the assessment occurred before the 
overwhelming majority of offspring initiated marijuana (Gray et al., 2005). 
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At the 10-year assessment, offspring were asked to report whether they had used alcohol, 
marijuana, or other illicit drugs. They completed a series of questions in the study protocol to 
ascertain patterns of substance use, including a question about the age at which they first tried 
marijuana (Jessor, Donovan, & Costa, 1989). These questions were also asked at the 14, 16, and 
22-year study visits. Where there were differences, the youngest reported age of initiation was 
used in these analyses. Early initiation was defined as use <16 years of age. A categorical 
variable was created: marijuana use before age 16, marijuana use at or after age 16, and never 
using marijuana. The age used to define early initiation of substances varies in the literature (R. 
Hayatbakhsh, Williams, Bor, & Najman, 2013; Kokkevi, Nic Gabhainn, Spyropoulou, & Risk 
Behaviour Focus Group of the HBSC, 2006; Lynskey et al., 2003). We selected 16 because it is 
below the average age of marijuana initiation in the US (Substance Abuse and Mental Health 
Services Administration [SAMSHA], 2012).   
The covariates in these analyses were maternal alcohol use during the first trimester and 
the offspring’s gender, age, and race. Maternal alcohol use during the first trimester was 
ascertained from questions about substance use patterns designed for the MHPCD study (Day & 
Robles, 1989). We adjusted for this variable because the analyses were conducted on the 
combined alcohol and marijuana cohorts. The offspring’s gender was ascertained from the birth 
assessment and age was calculated from the birth date. We adjusted for gender because males 
have a higher rate of CUD and age because there was variability at the 22-year assessment. We 
also adjusted for race because African American mothers were more likely to use marijuana than 
Caucasian mothers in this sample. Although the home environment at age 10 was assessed using 
the Home Observation for Measurement of the Environment-Short Form (HOME; Baker & 
Mott, 1989) and offspring child maltreatment was assessed at 22 years of age using the Child 
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Trauma Questionnaire (CTQ; Bernstein & Fink, 1998), neither variable was associated with the 
exposure and outcome in bivariate analyses. Therefore, these variables were not included as 
covariates in the final model. 
4.3.3 Analysis plan 
Analyses were performed on the combined marijuana and alcohol cohorts. We restricted our 
analyses to the first trimester for two reasons. First, approximately 9% of the participants did not 
complete the second trimester interview. Second, marijuana use declined during pregnancy. 
While 41% of the sample reported marijuana use during the first trimester, only 18% of the 
sample reported use by the third trimester (Figure 5). As a result, sample sizes in the second and 
third trimesters were not large enough to analyze patterns of exposure. Table 19 of the Appendix 
displays the sample sizes and marijuana use of the mothers across gestation. 
The distributions of marijuana and alcohol variables were examined. Out of range values 
for marijuana were set to 10.0 joints per day and the out of range values for alcohol use were set 
to 8.0 drinks per day.  
Descriptive statistics were generated to explore the associations between the variables 
considered for this analysis. We looked at the correlations and performed t-tests or analysis of 
variance (ANOVA) to evaluate continuous variables. For continuous variables that were not 
normally distributed, we used the Mann-Whitney U test or the Kruskal-Wallis test. We 
performed Chi-square tests to evaluate the association between dichotomous variables. Cohen’s 
d and Cramer’s V were calculated to assess effect size.  
Path analyses were performed with the Mplus version 5.2 (Muthén & Muthén, 2008). The 
mean and variance adjusted weighted least square (WLSMV) estimation method was used due to 
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the categorical dependent variables in this analysis. The fit of the path model was assessed using 
several indices. A value over 0.95 is considered good for the comparative fit index (CFI; Hu & 
Bentler, 1999). For the Tucker-Lewis Index (TLI), over .90 is considered a good fit, a Root 
Mean Square Error of Approximation (RMSEA) value of less than .06 is considered a good fit, 
and a Weighted Root Mean Square Residual (WRMR) of less than .90 is considered a good fit 
(Hu & Bentler, 1999; Yu, 2002). 
4.4 RESULTS 
Table 20 of the Appendix displays characteristics of the sample. At the initial visit, the average 
age of the mothers was 23 years (range: 18-42), 52% were African American, and 31% were 
married. The women completed an average of 11.8 years of education, 25% were in school or 
worked outside the home, and 61% had a household monthly income of less than $400 in 1982-
1985. Forty-one percent used marijuana and the average ADJ was 0.38, demonstrating a mean 
use of three times per week. Sixty-four percent of the mothers drank alcohol, 53% smoked 
cigarettes, 4% used cocaine, and 9% used other illicit drugs. 
At birth, 47% of the offspring were male. The average gestational age was 40 weeks and 
the average birth weight was 3.2kg. At 10 years of age, the offspring had an average CDI T-score 
of 45.99 (range: 35-79), with a higher score indicating more depressive symptoms. Fifty-one 
percent of the offspring used marijuana before age 16. At the 22-year assessment, the average 
age was 22.8 years and 57% of the offspring were African American. They had completed an 
average of 12.8 years of education, and 61% were working and/or in school. Their median 
monthly income was $800, 35% were living with their mother or a caregiver, 6% were married, 
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and 37% had at least one child. Forty-three percent reported smoking cigarettes, 92% reported 
drinking alcohol, 6% used cocaine, and 13% used other illicit drugs. Although 82% had used by 
the 22-year study phase, only 49% of offspring reported using marijuana in the past year. The 
prevalence of CUD was 14% in the total cohort and 16% among those who used marijuana.  
Table 7 displays sample characteristics by maternal first trimester marijuana use. For 
descriptive purposes, categories were created representing women who did not use marijuana 
during the first trimester, light to moderate users (<1 joint/day), and heavy users (≥1 joint/day). 
As the amount of PME increased, there was an increase in the percent of African American 
women, a household income less than $400, average daily volume of alcohol consumed, any use 
of tobacco, cocaine, or other drugs, and a decrease in the proportion of women who were 
married. There were no differences by maternal age, years of education completed, or average 
daily cigarettes. At birth, there were no significant differences in offspring gender, weight, or 
gestational age by PME category. At 10 years, offspring depressive symptoms increased as PME 
increased. At the 22-year assessment, the offspring with PME were slightly younger and more 
likely to be African American. There were no differences between those with PME and those 
without by years of education completed, whether they were working and/or in school, personal 
monthly income, marital status, or the percent living with a mother or caregiver. There were no 
differences according to past-year use of alcohol, cigarette, cocaine, or other illicit drugs. There 
was, however, a significant difference with marijuana use. The percent of those who reported 
past-year marijuana use increased as PME increased. Offspring ADJ also increased as PME 
increased. Although the rate CUD diagnoses increased as PME increased, this observation was 
not statistically significant.  
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Table 21 of the Appendix displays sample characteristics according to CUD diagnosis of 
the offspring. There were no differences between those with and without CUD, according to 
maternal demographic characteristics or maternal substance use. The offspring did not differ by 
gestational age or birth weight. There was a difference by gender. Among those with a CUD 
diagnosis, 74% were male compared to 43% among those without a CUD diagnosis. The number 
of depressive symptoms at age 10 did not differ by CUD status. On average, those without a 
CUD diagnosis completed one more year of education than those with a CUD diagnosis. There 
were no other significant demographic differences. While there was no difference in the 
proportion of past-year alcohol users, offspring with a CUD diagnosis consumed a higher ADV 
of alcohol and more often used other illicit substances. 
Hypothesis 1 was that PME would predict CUD. Although CUD diagnoses increased as 
PME increased, the association was not statistically significant in the bivariate analyses. 
Path models were used to test the remaining hypotheses. First, we fit the conceptual 
model (Appendix, Figure 8) and evaluated the pathways for significance. Depressive symptoms 
at age 10 did not predict CUD at age 22 (p=0.738). Thus, Hypothesis 2 was not supported. This 
path was removed to create a final parsimonious model. The overall fit for this model was good. 
There was no significant difference between the observed and model covariance matrices, χ2(2) = 
0.161, p = 0.923, CFI = 1.000, TLI = 1.134, RMSEA = 0.000, WRMR = 0.079 (Appendix, Table 
22). Table 8 displays the path results for this final model. 
Hypothesis 3 was that PME would predict depressive symptoms. This hypothesis was 
supported. We observed a significant positive prediction of depressive symptoms at age 10 by 
PME (β = 0.141; p<0.001). There was also a significant positive prediction of depressive 
symptoms at age 10 by prenatal alcohol exposure and gender, where male offspring had 
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significantly fewer depressive symptoms than females. Overall, 5% of the variance of depressive 
symptoms was explained by PME and covariates. 
Hypotheses 4 and 5 were that PME and depressive symptoms at age 10 would predict 
early initiation of marijuana, respectively. These hypotheses were supported. Offspring were 
16% more likely to initiate marijuana early for a one standard deviation increase in PME. A one 
standard deviation increase in depressive symptoms increased the likelihood of earlier marijuana 
initiation by 18%. Male offspring were 32% more likely to initiate marijuana earlier than 
females. For every one year increase in age, offspring were 15% less likely to initiate marijuana 
early. Overall, 9% of the variance of marijuana initiation was explained by PME, depressive 
symptoms, and the covariates. 
Hypothesis 6 was that early initiation of marijuana would predict CUD at age 22. This 
hypothesis was supported. Offspring who initiated marijuana early were 61% more likely be 
diagnosed with CUD. Male offspring were two times more likely to be diagnosed with CUD than 
females. Prenatal alcohol exposure, age, and race were not associated with CUD. Thirty-four 
percent of the variability of CUD was explained by marijuana initiation and the covariates.  
Our sample includes offspring who did not initiate marijuana as well as those who did. 
To assess the effects of this, we ran our models excluding those who did not initiate marijuana 
and observed a 12% reduction in the R2 of initiation predicting CUD diagnosis. The implications 
of this are that we may be overestimating the influence of initiation because CUD is a 
conditional diagnosis. However, in both samples, initiation was still the strongest contributor in 
the path to CUD.  
We considered whether these findings were specific to CUD diagnosis as opposed to any 
Substance Use Disorder (SUD). We excluded offspring with a CUD diagnosis and evaluated the 
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association between PME and any offspring SUD. SUD diagnosis did not increase as PME 
increased and the relationship was not significant in bivariate analyses (p=0.169). We also ran 
the path models with this reduced sample. The pathway from PME to SUD through early 
initiation of marijuana was marginally significant (p=0.090). The pathway from PME to SUD 
through depressive symptoms and early initiation of marijuana was also marginally significant 
(p=0.071). These results suggest that PME may be specific to CUD outcome but this should be 
evaluated in future studies. 
In conclusion, although the direct effect was not significant, there were two significant 
pathways representing the indirect effects of PME on CUD at age 22. The first was through early 
initiation of marijuana (p=0.013), and the second was through two intervening variables, 
depressive symptoms and early initiation of marijuana (p=0.023). 
4.5 DISCUSSION 
The goal of these analyses was to evaluate whether PME predicted offspring CUD in young 
adulthood, and whether depressive symptoms and early initiation of marijuana were in the 
pathway from PME to offspring CUD in young adulthood. The direct pathway from PME to 
CUD was not significant. However, we found a significant indirect path of PME to CUD through 
early initiation of marijuana. We also found a significant indirect path of PME to CUD through 
depressive symptoms and early initiation of marijuana.  
In our sample, the lifetime prevalence of CUD was 16% among those who used 
marijuana. Our rate is higher than the 8.5% listed by Stinson et al. (2006). Our cohort is 
composed of offspring of predominantly low-income women who used substances during 
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pregnancy, which may explain the differences. This is because our sample may be at a higher 
risk of CUD compared to the US national sample reported by Stinson et al. (2006). 
This analysis offers insight about the relationship between depressive symptoms, 
marijuana initiation, and CUD. Although marijuana use and CUD have been associated with 
depression and depressive symptoms, the relationship is unclear (Brook et al., 2011; Degenhardt, 
Hall, & Lynskey, 2003; Fergusson & Horwood, 1997). Depressive symptoms did not predict 
CUD in this study.  However, the longitudinal nature of the study allowed us to assess depressive 
symptoms before marijuana initiation and demonstrate that depressive symptoms predicted early 
initiation, which in turn predicted CUD. This is consistent with recent findings on 12 to 17-year-
old participants from the National Survey on Drug Use and Health (NSDUH; SAMSHA, 2007). 
Subjects who reported a major depressive episode in the past were more likely to initiate 
marijuana use than were those who did not experience a major depressive episode. Further, 
depressive symptoms have been shown to be associated with the initiation of other substances (P. 
Wu et al., 2006). This topic needs further exploration in data sets that can establish a temporal 
relationship of depressive symptoms, marijuana use, and Substance Use Disorders. 
This study had several limitations. Although self-report of substance use may be 
considered a limitation, efforts were made to encourage accurate reporting. At the first prenatal 
visit, a bogus pipeline procedure was used for the mothers and a urine screen was part of the 
study protocol for the offsprings’ reports of substance use. Further, the staff members who 
interviewed the participants were comfortable asking questions about the sensitive topics (e.g., 
substance use, psychosocial factors) and followed an established protocol for the sequence of 
questioning. In addition, a NIH Certificate of Confidentiality allowed us to reassure the clients 
that their data were confidential.  
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This study had several strengths. First, this sample is heterogeneous with 52% of the 
mothers being African American and 48% Caucasian. Second, there was excellent follow-up 
with 80% of the birth cohort interviewed at age 22. Third, the large sample size allowed us to use 
a path analysis to test our hypotheses. Lastly, the prospective nature of the data collection 
allowed use to minimize recall bias and establish a temporal sequence of events to evaluate 
pathways from PME to CUD.  
In conclusion, to the best of our knowledge, this is the first study to evaluate potential 
pathways from PME to CUD in young adulthood. Our findings are important because CUD is a 
preventable public health problem and there are currently no approved medications to treat CUD 
(Danovitch & Gorelick, 2012). While behavioral therapy has been shown to be effective, the 
success rates are poor to modest with about 9-29% of individuals treated reporting abstinence 
after one year (Budney, Roffman, Stephens, & Walker, 2007). Thus, we need to develop 
methods to prevent the development of CUD.   
Our results identify several time points for intervention. Pregnancy is a time when 
women have frequent contact with healthcare providers and should be encouraged to abstain 
from marijuana. Depressive symptoms are a risk factor for marijuana initiation. This knowledge 
is important for parents and healthcare providers because children can easily be screened for 
depressive symptoms and offered treatment. Finally, public health efforts should be targeted 
toward delaying initiation of marijuana as this is a risk factor for CUD.  This will be particularly 
salient as states continue to adopt policies permitting medical and recreational marijuana use. 
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4.7 TABLES AND FIGURES 
Table 7. Sample characteristics by category of first trimester marijuana use 
 
Nonea 
(n=350) 
Light to 
Moderateb 
(n=161) 
Heavyc 
(n=79) p-valued 
Effect 
Sizee 
Maternal Characteristics at the First 
Trimester Visit 
     
Age (mean years) 23.29 22.57 22.87 0.161 0.006 
Education (mean years) 11.89 11.84 11.70 0.522 0.002 
Race (% African American) 46.86 52.17 75.95 <0.001 0.193 
Marital status (% married) 36.57 26.09 17.72 0.001 0.150 
Employment status (% in school or 
worked outside the home) 25.43 30.43 15.19 0.039 0.105 
Household income <US$400/month (%)f  56.89 64.38 72.73 0.022 0.115 
Alcohol use (%) 55.14 77.02 74.68 <0.001 0.216 
Average daily volume of alcohol 0.40 0.75 0.86 <0.001 0.031 
Cigarette use (%) 46.57 60.25 67.09 0.001 0.162 
Average daily cigarettes 7.40 8.80 9.53 0.195 0.006 
Cocaine use (%) 1.43 5.59 8.86 0.001 0.149 
Other illicit drug use (%) 6.86 9.32 15.19 0.055 0.099 
Offspring Characteristics at Birth      
Gender (% male) 47.14 47.83 45.57 0.947 0.014 
Birth weight 3.21 3.23 3.09 0.180 0.006 
Gestational age 39.70 39.93 39.86 0.486 0.002 
Offspring Characteristics at 10 Years      
Children’s Depression Inventory T-
Score (mean)g 45.36 45.70 49.19 0.005 0.023 
Marijuana initiation 
    Before age 16 (%) 
    Between ages 16-22 
    Never 
 
47.71 
30.57 
21.71 
 
50.31 
36.65 
13.04 
 
63.29 
27.85 
8.86 
0.009 0.107 
Offspring Characteristics at 22 Years      
Age (years) 22.89 22.77 22.69 0.029 0.012 
Race (% African American) 52.86 54.66 79.75 <0.001 0.182 
Employed or in school (%) 61.71 63.98 51.90 0.180 0.076 
Education (years) 12.82 12.95 12.42 0.054 0.001 
Personal income (median US$/month)h 800 800 650 0.257 0.006 
Lives with mother or caregiver (%) 37.71 31.06 32.91 0.307 0.063 
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Marital status (% married) 5.14 7.45 3.80 0.433 0.053 
Past-year alcohol use (%) 92.00 93.17 92.41 0.899 0.019 
Average daily volume of alcohol 1.44 1.85 1.62 0.044 0.007 
Past-year cigarette use (%) 40.00 44.72 51.90 0.133 0.083 
Average daily cigarettes 3.80 4.81 5.28 0.120 0.007 
Past-year marijuana use (%) 43.14 55.28 62.03 0.002 0.147 
Average daily joints 0.67 0.69 1.70 <0.001 0.028 
Past-year cocaine use (%) 4.86 8.70 8.86 0.167 0.078 
Past-year other illicit drug use (%) 11.43 14.91 18.99 0.164 0.078 
Cannabis Use Disorder (%) 12.86 14.29 15.19 0.819 0.026 
Cannabis Use Disorder among lifetime 
marijuana users (%) 
16.42 16.43 16.67 0.999 0.002 
a Zero joints per day  
b Less than 1 joint per day 
c One or more joints per day  
d ANOVA for continuous variables, Kruskal-Wallis test for skewed variables, χ2 test for 
dichotomous variables 
e Eta2 for continuous variables, Cramer’s V for dichotomous variables; absolute value reported 
f Sample sizes: 334, 160, 77  
g Sample sizes: 301, 145, 72 
h Sample sizes: 341, 157, 77 
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Table 8. Path results for final model 
 B β z p R2 
Depressive Symptoms  PME     0.049 
     Prenatal marijuana exposure 1.374 0.152 3.734 <0.001  
     Prenatal alcohol exposure 0.603 0078 2.102 0.036  
     Offspring gender -1.838 -0.108 -2.469 0.014  
     Offspring age -0.250 -0.021 -0.430 0.667  
     Offspring race -0.580 -0.034 -0.746 0.456  
Early Initiation  Depressive Symptoms and PME     0.092  
     Depressive symptoms 0.020  0.165  3.497  <0.001  
     Prenatal marijuana exposure 0.163 0.146 2.543 0.011  
     Prenatal alcohol exposure 0.070 0.074 1.538 0.124  
     Offspring gender 0.284 0.135 2.880 0.004  
     Offspring age -0.162 -0.108 -2.335 0.020  
     Offspring race 0.120 0.057 1.219 0.223  
CUD  Early Initiation     0.341 
     Early Initiation 0.562 0.479 4.957 <0.001  
     Prenatal alcohol exposure 0.016 0.014 0.272 0.786  
     Offspring gender 0.700 0.284 4.430 <0.001  
     Offspring age -0.050 -0.028 -0.480 0.631  
     Offspring race -0.091 -0.037 -0.569 0.569  
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Figure 5. Maternal marijuana use by trimester 
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Figure 6. Final path model 
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5.0  DISCUSSION AND CONCLUSIONS 
5.1 OVERVIEW OF FINDINGS 
The goal of this dissertation was to evaluate the effects of PME on frequency of offspring 
marijuana use and CUD in offspring in young adulthood. The main findings and a summary of 
each paper are presented. 
In Paper 1, we evaluated the association between PME and frequency of offspring 
marijuana use in young adulthood. Using a simple ordinal logistic regression model, PME 
significantly predicted frequency of offspring marijuana use at 22 years. This finding was 
attenuated to non-significance after adjusting for prenatal alcohol exposure, the home 
environment and maternal marijuana use at the 10-year assessment, and the offspring’s race, 
gender, age, and history of childhood maltreatment. The association between PME and 
frequency of offspring use was moderated by a history of childhood maltreatment, but not by 
race or gender. The interaction between PME and offspring childhood maltreatment suggested 
that PME was associated with frequency of offspring use at low levels of childhood 
maltreatment, but not at high levels of childhood maltreatment. 
In Paper 2, we examined the role of several intervening variables in the pathway from 
PME to offspring frequency of use in young adulthood. We did not find significant pathways 
when considering aggression, anxiety, attention or delinquent behavior at age 10. We did observe 
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significant indirect paths when considering offspring depressive symptoms and early initiation of 
marijuana. Offspring depressive symptoms were self-reported at age 10 and early initiation of 
marijuana defined as first use before age 16, first use at age 16 or older, and never used. After 
adjusting for prenatal alcohol exposure, the home environment, and the offspring’s age, gender, 
race, and history of childhood maltreatment, there was a significant indirect path of PME on 
offspring frequency of use through early initiation of marijuana. There was also a significant 
indirect path of PME on offspring frequency of use through depressive symptoms and early 
initiation of marijuana. Further, we found that PME was a significant path to initiation, but 
maternal marijuana use when the offspring were 10 years of age did not predict initiation. 
In Paper 3, we examined the role of offspring depressive symptoms and early initiation of 
marijuana as variables in the pathway from PME to CUD. Offspring depressive symptoms were 
self-reported at age 10 and early initiation of marijuana was defined as first use before age 16, 
first use at age 16 or older, and never used. After adjusting for prenatal alcohol exposure and the 
offspring’s age, gender, and race, there was a significant indirect path of PME on CUD through 
early initiation of marijuana. There was also a significant indirect path of PME on CUD through 
depressive symptoms and early initiation of marijuana. 
5.2 STRENGTHS AND LIMITATIONS 
The strengths of the MHPCD study make these dissertation papers important contributions to the 
literature. First, this data set is unique because it has assessments of the patterns of substance use 
during pregnancy and the offspring who were followed through young adulthood. There are few 
data sets in the world that have such data about prenatal marijuana exposure and offspring 
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substance use. Second, the study population was a racially heterogeneous sample. About half of 
the women recruited for the study were African American and the other half were Caucasian.  
This allowed us to test for interactions by race, and broadly report information about offspring 
marijuana use and CUD in the cohort by race. Third, the retention rate of the sample is 
outstanding. The efforts made to track the mothers and their offspring have resulted in 80% of 
the birth cohort being available for analysis at the 22 year period.  
Despite these noted strengths, there are a few limitations to this dissertation. This sample 
is composed of predominately low income women, and the results may not be generalizable to 
women in higher socioeconomic groups. Additionally, marijuana use was ascertained by self-
report. However, a bogus pipeline procedure was used to encourage honest reporting from 
mothers at the first prenatal visit. In addition, a urine screen was part of the study protocol for the 
offspring. Further, the staff members who interviewed the participants were comfortable asking 
questions about the sensitive topics (e.g., substance use, psychosocial factors) and followed an 
established protocol for the sequence of questioning. In addition, a National Institutes of Health 
Certificate of Confidentiality was obtained for this study because of the sensitive nature of topics 
discussed. This provides research participants with a sense of confidentiality and privacy because 
it offers protection from the release of identifying information when requested through court 
order or subpoena. 
5.3 PUBLIC HEALTH SIGNIFICANCE 
The findings of this dissertation are significant to public health. Marijuana is the most widely-
used illicit substance during pregnancy. Findings from the National Pregnancy and Health 
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Survey conducted in 1992-1993 indicate that 2.9% of women used marijuana at some point 
during pregnancy (NIDA, 1996). And, while animal and human models do not suggest that PME 
is associated with physical defects seen at birth, the findings of this dissertation contribute to the 
body of literature on the long-term behavioral effects on offspring. Further, the THC content in 
marijuana has doubled since the 1980s when the women were recruited for this study (UNODC, 
2012). Therefore, our results may underestimate the effects we would see in a cohort recruited 
today. 
Public health intervention can take many forms. First, pregnancy is a time of frequent 
contact with a healthcare provider. Providers can educate women about the potential risks of 
marijuana use and encourage them to abstain during pregnancy. Second, our results 
demonstrated that child depressive symptoms predicted early initiation of marijuana. Parents and 
healthcare providers should be educated about this risk. If depressive symptoms are suspected, 
then a pediatrician can administer a screening tool during an office visit. The results of the 
screening tool can be used to determine whether the child should be referred elsewhere for 
possible treatment. Third, educational programs about the consequences of marijuana use should 
continue to be targeted toward youth. Programs could focus on refraining from using marijuana; 
however, delaying initiation of marijuana would also be a desirable outcome. This is especially 
important now that states have authorized the legal use of marijuana for medical purposes and 
recreational use. 
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5.4 FUTURE DIRECTIONS OF RESEARCH 
The findings of this dissertation suggest that PME may create a vulnerability for offspring. 
Future work in this sample could include following this cohort for a longer period of time, as the 
offspring in the sample are now about the age of 30. It would be interesting to evaluate the 
patterns of marijuana use at this age, as well as the lifetime prevalence of CUD in this high-risk 
sample.  
Another opportunity for research would be to repeat this study in another sample. The 
findings would be an important contribution to the literature, as the results could be compared to 
those of the OPPS and MHPCD study. Further, because the THC content of marijuana has 
doubled since this study began, it is plausible that the effects of the MHPCD study underestimate 
what would be seen in a cohort recruited today. Finally, with the recent introduction of synthetic 
marijuana, there is an opportunity to look at the long-term effects of prenatal exposure to this 
substance as well. Little is known about synthetic marijuana use patterns, and researchers do not 
yet know if the effects are the same as marijuana.  
5.5 CONCLUSIONS 
The goal of this dissertation was to evaluate the effects of PME on offspring frequency of 
marijuana use and CUD at 22 years. While PME was not a significant predictor of offspring 
frequency of use at 22 years after adjusting for environmental and psychosocial variables, there 
were significant indirect pathways from PME to frequency of use. We also demonstrated 
significant pathways from PME to CUD.  
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 The results of this dissertation suggest that PME may create a vulnerability for offspring, 
and this is an important contribution to the literature. These findings support the need to focus 
public health efforts on the prevention of marijuana use and educating the public about the 
potential risks of using this substance. Our findings are particularly relevant to pregnant women, 
who should be encouraged to abstain from marijuana. 
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APPENDIX: ADDITIONAL TABLES AND FIGURES 
Table 9. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, criteria for 
Cannabis Use Disorder 
Abuse A maladaptive pattern of cannabis use leading to clinically significant 
impairment or distress, as manifested by one or more of the following, during 
a 12 month period:  
1. Recurrent cannabis use that interferes with major role 
obligations at work, school, or home. Examples include 
frequent absences, poor performance, suspensions, job loss or 
expulsion from school, neglect of children or household.  
2. Recurrent cannabis use in situations in which it is physically 
hazardous. Examples include driving or operating machinery 
when intoxicated.  
3. Recurrent legal problems related to cannabis use.  
4. Persistent cannabis use despite continued social or 
interpersonal problems caused or exacerbated by the effects of 
cannabis, such as arguments with a spouse about the 
consequences of intoxication.  
The symptoms have never met criteria for cannabis dependence. 
 
Dependence A maladaptive pattern of cannabis use resulting in clinically significant 
impairment or distress, as indicated by three or more of the following at any 
time during the same 12 month period:  
1. Tolerance, defined by either of the following:  
a. Using markedly increased amounts of cannabis to achieve 
the desired effect or intoxication.  
b. Markedly diminished effect with continued use of the same 
amount of cannabis.  
1. Cannabis is often taken in larger amounts or over a longer 
period than was intended. 
2. There is a persistent desire or there are unsuccessful efforts to 
cut down or control cannabis use. 
3. A great deal of time is spent obtaining cannabis, using it, or 
recovering from its effects. 
4. Important social, occupational, or recreational activities are 
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neglected because of cannabis use. 
Persistent cannabis use despite knowledge of having a recurrent or ongoing 
physical or psychological problem that is probably caused or exacerbated by 
cannabis, such as a chronic cough related to smoking or a decrease in goal 
related activities. 
 
Table 10. Chapter 2: First trimester maternal characteristics of offspring included in and excluded from the 
analyses 
Maternal Characteristics First 
Trimester 
Included in 
Analyses 
(n=589) 
Excluded 
from Analyses 
(n=174) p-valuea 
Effect 
Sizeb 
Age (mean years) 23.06 22.95 0.752 0.027 
Race (% African American)  51.44 51.72 0.948 0.002 
Education (mean years) 11.83 11.91 0.532 0.054 
Marital status (% married) 32.09 35.06 0.463 0.027 
Household income (mean US$/mo) 300-399c 300-399d 0.407 0.073 
Average daily volume of alcohol 0.55 0.77 0.137 0.164 
Any alcohol use (%) 64.18 67.24 0.457 0.030 
Average daily joints of marijuana 0.37 0.43 0.931 0.057 
Any marijuana use (%) 41.09 38.51 0.542 0.022 
Average daily cigarettes 8.17 8.89 0.471 0.062 
Any cigarette use (%) 53.14 58.05 0.254 0.041 
Any cocaine use (%) 3.74 4.02 0.862 0.006 
Any other illicit drug use (%) 8.83 9.20 0.881 0.005 
at-test for continuous variables, Mann Whitney test for skewed variables, χ2 test for dichotomous 
variables 
bCohen’s d for continuous variables, Cramer’s V for dichotomous variables; absolute value 
reported 
csample size 570 
dsample size 166 
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Table 11. Chapter 2: Maternal marijuana use by trimester 
 First Trimester N = 589 
Second Trimester 
N = 532 
Third Trimester 
N = 589 
No usea (n, %) 347 (58.91) 415 (78.01) 481 (81.66) 
Light to moderate useb (n, %) 165 (28.01) 91 (17.11) 76 (12.90) 
Heavy usec (n, %) 77 (13.07) 26 (4.89) 32 (5.43) 
a Zero joints per day  
b Less than one joint per day 
c One or more joints per day  
 
Table 12. Chapter 2: Sample characteristics 
 Total 
N 
Mean 
or n 
Standard 
deviation 
or % 
Range 
Maternal Characteristics at the First Trimester Visit 
Age (mean years) 589 23.06 4.04 18-42 
Race (n, % African American) 589 303 51.44  
Education (mean years) 589 11.83 1.36 7-18 
Marital status (n, % married) 589 189 32.09  
Employment status (n, % in school and/or 
working outside the home) 
589 150 25.47  
Household income (n, %<US$400/month) 589 350 61.40 0-1000+ 
Depression (mean CES-D score) 585 20.96 8.59 1-51 
Anxiety (mean STPI score) 588 17.74 4.65 10-39 
Hostility (mean STPI score) 588 18.73 5.75 10-40 
Any alcohol use (n, %) 589 378 64.13  
Average daily volume of alcohol among cohort 589 0.55 1.07 0-8 
Average daily volume of alcohol among users 382 0.85 1.24 0.0057-8 
Any marijuana use (n, %) 589 242 41.09  
Average daily joints of marijuana among cohort 589 0.37 0.93 0-7.4 
Average daily joints of marijuana among users 242 0.91 1.27 0.0011-7.4 
Any cigarette use (n, %) 589 313 53.14  
Average daily cigarettes among cohort 589 8.17 11.37 0-50 
Average daily cigarettes among users 313 15.38 11.50 0.5-50 
Any cocaine use (n, %) 589 22 3.74  
Any other illicit drug use (n, %) 589 52 8.83  
Offspring Characteristics at Birth 
Gender, % male) 589 278  47.20  
Gestational age (mean weeks) 589 39.80  2.19 28-44 
Preterm birth (n, % <37 weeks) 589 48 8.15  
Birthweight (mean kg) 589 3.20 0.57 1.04-4.99 
Low birth weight (n, %<2500g) 589 59 10.02  
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Characteristics at 10 Years 
Home environment score (mean) 514 12.71 2.69 3-18 
Maternal average daily joints among cohort 520 0.07 0.28 0-2.6 
Maternal average daily joints among users 110 0.37 0.54 0.0015-2.6 
Any maternal marijuana use (n, %) 520 110 21.15  
Maternal average daily volume of alcohol among 
cohort 
520 0.91 1.59 0-8 
Maternal average daily volume of alcohol among 
alcohol users 
407 1.16 1.71 0.0075-8 
Any maternal alcohol use (n, %) 520 407 78.27  
Maternal average daily cigarettes among cohort 520 9.16 10.85 0-50 
Maternal average daily cigarettes among cigarette 
smokers 
305 15.62 10.00 .5-50 
Any maternal cigarette use (n, %) 520 305 58.65  
Any maternal other illicit drug use (n, %) 520 43 8.27  
Characteristics at 16 Years 
Parental acceptance/involvement score (mean) 499 30.21 4.38 15-36 
Parental psychological autonomy score (mean) 499 24.19 4.83 9-36 
Parental strictness/supervision score (mean) 493 18.88 3.97 8-30 
Parental authoritativeness overall score (mean) 493 1.42 0.94 0-3 
Offspring has peers who use cigarettes (n, %) 503 400 79.52  
Offspring has peers who drink alcohol (n, %) 503 399 79.32  
Offspring has peers who smoke marijuana (n, %) 502 375 74.70  
Offspring Characteristics at 22 Years 
Age (mean years) 589 22.84 0.70 21.16-26.09 
Race (n, % African American) 589 331 56.20  
Education (mean years)  589 12.79 1.63 8-18 
Completed high school (n, %) 589 510 86.59  
Personal income (mean US$/month) 574 969.46 861.10 0-5000 
Median personal income (US$/month) 574 800  0-5000 
Work status (n, % working and/or in school) 589 360 61.12  
Marital status (n, % married) 589 35 5.94  
Lives with mother or caregiver (n, %) 589 205 34.80  
Has at least one child (n, %) 589 217 36.04  
Child maltreatment score (mean) 589 2.43 1.08 1-5 
Experienced moderate, severe, or extreme child 
maltreatment (n, %) 
589 172 29.20  
Family history of alcohol or drug problems (n, %) 587 275 46.85  
Initiated cigarettes (n, %) 589 481 81.66  
Past-year cigarette smoker (n, %) 589 256 43.46  
Average daily cigarettes among cohort 589 4.36 7.01 0-50 
Average daily cigarettes among cigarette smokers 256 10.03 7.50 0.5-50 
Initiated alcohol (n, %) 589 584 99.15  
Past-year alcohol user (n, %) 589 545 92.53  
Average daily volume of alcohol among cohort 589 1.58 2.18 0-8 
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Average daily volume of alcohol among alcohol 
users 
545 1.72 2.21 0.01-8 
Initiated marijuana (n, %) 589 489 83.02  
Past-year marijuana user (n, %) 589 295 50.08  
Average daily joints of marijuana among cohort 589 0.82 2.06 0-10 
Average daily joints of marijuana among 
marijuana users 
295 1.65 2.67 0.0025-10 
Any cocaine use in past year (n, %) 589 39 6.62  
Any other illicit drug use in past year (n, %) 589 81 13.75  
 
Table 13. Chapter 3: First trimester maternal characteristics of offspring included in and excluded from the 
analyses 
Maternal Characteristics Assessed at 
the First Trimester 
Included in 
Analyses 
(n=585) 
Excluded 
from Analyses 
(n=178) p-valuea 
Effect 
Sizeb 
Age (mean years) 23.04 22.90 0.611 0.044 
Race (% African American) 51.62 51.12 0.907 0.004 
Education (mean years) 11.84 11.87 0.824 0.019 
Marital status (% married) 31.97 35.39 0.394 0.031 
Household income (mean US$/mo)c 300-399 300-399 0.479 0.062 
Average daily volume of alcohol 0.55 0.77 0.125 0.199 
Alcohol use (%) 64.10 67.42 0.417 0.029 
Average daily joints of marijuana 0.38 0.42 0.813 0.045 
Marijuana use (%) 41.20 38.20 0.476 0.026 
Average daily cigarettes 8.13 9.02 0.266 0.079 
Cigarette use (%) 53.16 57.87 0.270 0.040 
Cocaine use (%) 3.76 3.93 0.916 0.004 
Other illicit drug use (%) 8.89 8.99 0.967 0.002 
at-test for continuous variables, Mann Whitney test for skewed variables, χ2 test for dichotomous 
variables 
bCohen’s d for continuous variables, Cramer’s V for dichotomous variables; absolute value 
reported 
csample size 566, 170 
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Table 14. Chapter 3: Maternal marijuana use by trimester 
 First Trimester N = 585 
Second Trimester 
N = 528 
Third Trimester 
N = 585 
No usea (n, %) 344 (58.80) 413 (78.22) 478 (81.71) 
Light to moderate useb (n, %) 164 (28.03) 89 (16.86) 75 (12.82) 
Heavy usec (n, %) 77 (13.16) 26 (4.92) 32 (5.47) 
aZero joints per day  
bLess than one joint per day 
cOne or more joints per day  
 
 
Table 15. Chapter 3: Sample characteristics 
 Total 
N 
Mean 
or n 
Standard 
Deviation 
or % 
Range 
Maternal Characteristics at the First Trimester Visit 
Age (mean years) 585 23.07 4.05 18-42 
Race (n, % African American) 585 302 51.62  
Education (mean years) 585 11.84 1.35 7-18 
Marital status (n, % married) 585 187 31.97  
Work status (n, % working outside the home 
and/or in school) 
585 150 25.64  
Household income (n, %<US$400/month) 566 347 61.31 0-1000+ 
Alcohol use (n, %) 585 375 64.10  
Average daily volume of alcohol 585 0.55 1.08 0-8 
Marijuana use (n, %) 585 241 41.20  
Average daily joints of marijuana 585 0.38 0.93 0-7.4 
Cigarette use (n, %) 585 311 53.16  
Average daily cigarettes 585 8.13 11.33 0-50 
Cocaine use (n, %) 585 22 3.76  
Other illicit drug use (n, %) 585 52 8.89  
Offspring Characteristics at Birth 
Gender (n, % male) 585 275 47.01  
Gestational age (mean weeks) 585 39.79  2.19 28-44 
Birth weight (mean kg) 585 3.19 0.57 1.04-4.99 
Characteristics at 10 Years 
Home environment (mean score) 510 12.70 2.69 3-18 
Depressive symptoms (mean T-score)  510 45.94 8.37 35-77 
Anxiety (mean score) 509 10.06 6.23 0-28 
Attention (mean score) 515 8.84 2.95 5-20 
Delinquent behavior (mean T-score) 515 55.98 6.99 50-94 
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Maternal average daily joints  516 0.07 0.28 0-2.6 
Characteristics at 16 Years     
Parenting authoritativeness (mean score) 490 1.43 0.94 0-3 
Offspring Characteristics at 22 Years 
Age (mean years) 585 22.84 0.70 21.16-26.09 
Race (n, % African American) 585 330 56.41  
Education (mean years)  585 12.79 1.64 8-18 
Employment status (n, % working and/or in 
school) 
585 359 61.37  
Median personal income (US$/month) 570 800  0-5000 
Lives with mother or caregiver (n, %) 585 204 34.87  
Marital status (n, % married) 585 34 5.81  
Has at least one child (n, %) 585 215 36.75  
Child maltreatment (mean score) 585 2.42 1.08 1-5 
Experienced moderate, severe, or extreme child 
maltreatment (n, %) 
585 168 28.72  
Past-year cigarette use (n, %) 585 252 43.08  
Average daily cigarettes  585 4.33 7.02 0-50 
Past-year alcohol use (n, %) 585 541 92.48  
Average daily volume of alcohol  585 1.59 2.18 0-8 
Marijuana initiation (n, %) 
   Initiated <16 years 
   Initiated ≥16 years 
   Never initiated 
585  
296 
189 
100 
 
50.60 
32.31 
17.09 
 
Past-year marijuana use (n, %) 585  291 49.74  
Average daily joints of marijuana 585 0.82 2.06 0-10 
Frequency of marijuana use (%) 
    No use 
    Use <3 times per week 
    Use ≥3 times per week 
585 
 
 
294 
172 
119 
 
50.26 
29.40 
20.34 
 
Past-year cocaine use (n, %) 585 39 6.67  
Past-year other illicit drug use (n, %) 585 79 13.50  
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Table 16. Chapter 3: Characteristics by offspring frequency of marijuana use 
 Offspring Frequency of Marijuana Use 
 
No Use 
(n=294) 
Use <3 
times per 
week 
(n=172) 
Use ≥3  
times per 
week 
(n=119) p-valued 
Effect 
sizee 
Maternal Characteristics First 
Trimester      
Age (mean years) 22.97 23.13 23.24 0.658 0.001 
Race (% African American)  46.60 49.42 67.23 <0.001 0.160 
Education (mean years) 11.95 11.70 11.80 0.141 0.007 
Marital status (% married) 37.76 27.33 24.37 0.009 0.127 
Employment status (% working outside 
the home and/or in school) 24.15 27.33 26.89 0.706 0.035 
Household income (%<US$400/month)f 58.36 64.88 63.25 0.347 0.061 
Alcohol use (%) 61.90 63.95 69.75 0.322 0.062 
Average daily volume of alcohol 0.41 0.70 0.65 0.062 0.015 
Cigarette use (%) 50.68 54.65 57.14 0.441 0.053 
Average daily cigarettes 7.46 9.79 7.39 0.272 0.009 
Marijuana use (%) 34.01 43.02 56.30 <0.001 0.174 
Average daily joints of marijuana 0.27 0.41 0.59 <0.001 0.018 
Cocaine use (%) 3.40 5.23 2.52 0.440 0.053 
Other illicit drug use (%) 7.82 10.47 9.24 0.619 0.041 
Offspring Characteristics at Birth 
Gender (% male) 40.82 48.84 59.66 0.002 0.146 
Gestational age (mean weeks) 40.00 39.62 39.54 0.297 0.009 
Birth weight (mean kg) 3.25 3.15 3.11 0.039 0.011 
Characteristics at 10 years 
Home environmentg (mean score) 13.04 12.43 12.28 0.034 0.016 
Depressive symptomsi (mean score) 45.25 45.51 48.22 0.008 0.019 
Anxietyj (mean score) 9.62 10.19 10.95 0.007 0.117 
Attentionk (mean score) 8.38 8.97 9.78 <0.001 0.033 
Delinquent behaviork (mean score) 55.33 56.54 56.72 0.075 0.009 
Maternal average daily jointsh 0.04 0.08 0.10 0.049 0.007 
Characteristics at 16 years 
Parental authoritativenessl 1.44 1.47 1.34 0.588 0.002 
Offspring Characteristics at 22 years 
Age (mean years) 22.92 22.75 22.78 0.030 0.012 
Race (% African American) 52.04 54.65 69.75 0.004 0.138 
Education (mean years) 13.08 12.71 12.19 <0.001 0.044 
Work status (% working and/or in 
school) 68.03 56.98 51.26 0.002 0.143 
Median personal income (US$/month)m 937 800 672 <0.001 0.037 
Marital status (% married) 9.18 2.91 1.68 0.002 0.146 
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Lives with mother or caregiver (%) 37.07 35.47 28.57 0.255 0.068 
Has at least one child (%) 32.99 37.79 44.54 0.083 0.092 
Childhood maltreatment (mean score) 2.27 2.62 2.53 0.003 0.023 
Marijuana initiation (%) 
     >16 years 
     ≥16 years 
     Never 
 
35.03 
30.95 
34.01 
 
60.47 
39.53 
0.00 
 
74.79 
25.21 
0.00 
<0.001 0.340 
Past-year cigarette use (%) 27.55 55.81 63.03 <0.001 0.319 
Average daily cigarettes  2.84 5.62 6.13 <0.001 0.046 
Past-year alcohol use (%) 87.76 97.67 96.64 <0.001 0.181 
Average daily volume of alcohol  1.00 1.93 2.58 <0.001 0.087 
Past-year cocaine use (%) 1.70 15.12 6.72 <0.001 0.214 
Past-year other illicit drug use (%) 3.40 19.77 29.41 <0.001 0.313 
Lifetime history of Cannabis Use 
Disorder (%)n 6.19 16.67 28.70 <0.001 0.254 
Arrested ≥1 times (%) 24.49 43.02 63.03 <0.001 0.310 
a Zero joints per day  
b Less than one joint per day 
c One or more joints per day  
d ANOVA for continuous variables, Kruskal-Wallis test for skewed variables, χ2 test for 
dichotomous variables 
e Eta2 for continuous variables, Cramer’s V for dichotomous variables; absolute value reported 
f Sample size: 281, 168, 117 
g Sample size: 252, 155, 103 
h Sample size: 255, 156, 105 
i Sample size: 252, 154, 104 
j Sample size: 249, 156, 104 
k Sample size: 255, 156, 104 
l Sample size: 248, 149, 93 
m Sample size: 286, 168, 116 
n Sample size: 291, 168, 115 
 
Table 17. Chapter 3: Fit indices for models tested during model identification 
Model  χ2 df p CFI TLI RMSEA WRMR 
1 – Conceptual model 0.000 0 0.000 1.000 1.000 0.000 1.000 
2 – Removed Offspring Use  PME 0.041 1 0.840 1.000 1.076 0.000 0.017 
3 – Removed Offspring Use  
Depressive symptoms 0.424 2 0.809 1.000 1.063 0.000 0.055 
4 – Added paths: 
Maternal Use  PME 
Early Initiation  Maternal Use 
0.969 3 0.809 1.000 1.054 0.000 0.085 
CFI=Comparative Fit Index (cut-off >.95), TLI= Tucker Lewis Index (cut-off >.90),  
RMSEA = Root Mean Square Error of Approximate (cut-off <.06), WRMR = Weighted Root  
Mean Square Residual (cut-off <.90) 
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Figure 7. Chapter 3: Conceptual path model 
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Table 18. Chapter 4: First trimester maternal characteristics of offspring included in and excluded from the 
analyses 
Maternal Characteristics Assessed at 
the First Trimester 
Included in 
Analyses 
(n=590) 
Excluded 
from Analyses 
(n=173) p-valuea 
Effect 
Sizeb 
Age (mean years) 23.03 23.03 0.989 0.001 
Race (% black) 52.20 49.13 0.477 0.026 
Education (mean years) 11.85 11.85 0.992 0.001 
Marital status (% married) 31.19 38.15 0.086 0.062 
Household income (mean US$/mo) 300-399c 300-399d 0.794 0.008 
Average daily volume of alcohol 0.55 0.75 0.073 0.166 
Alcohol use (%) 63.73 68.79 0.220 0.044 
Average daily joints of marijuana 0.38 0.41 0.829 0.035 
Marijuana use (%) 40.68 39.88 0.852 0.007 
Average daily cigarettes 8.07 9.25 0.214 0.104 
Cigarette use (%) 53.05 58.38 0.216 0.045 
Cocaine use (%) 3.56 4.62 0.519 0.023 
Other illicit drug use (%) 8.64 9.83 0.631 0.017 
at-test for continuous variables, Mann Whitney test for skewed variables, χ2 test for dichotomous 
variables 
bCohen’s d for continuous variables, Cramer’s V for dichotomous variables; absolute value 
reported 
csample size 571 
dsample size 165 
 
Table 19. Chapter 4: Maternal marijuana use by trimester 
 First N = 590 
Second 
N = 534 
Third 
N = 590 
Nonea (n, %) 350 (59.32) 419 (78.46) 482 (81.69) 
Light to moderateb (n, %) 161 (27.29) 88 (16.48) 77 (13.05) 
Heavy usersc (n, %) 79 (13.39) 27 (5.06) 31 (5.25) 
a Zero joints per day  
b Less than 1 joint per day 
c One or more joints per day  
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Table 20. Chapter 4: Sample characteristics 
n 
Mean (SD) or 
n (percent) Range 
Maternal Characteristics at the First Trimester Visit 
Age (years) 590 23.03 (4.04) 18-42 
Race (% African American) 590 308 (52.20) 
Marital status (% married) 590 184 (31.19) 
Education (years) 590 11.85 (1.36) 7-18 
Employment status (% in school and/or worked outside 
the home) 590 150 (25.42) 
Household income (n, %<US$400/month) 571 349 (61.12) 0-1000+ 
Marijuana use (%) 590 240 (40.68) 
Average daily joints of marijuana 590 0.38 (0.94) 0-7.4 
Alcohol use (%) 590 376 (63.73) 
Average daily volume of alcohol 590 0.55 (1.10) 0-8 
Cigarette use (%) 590 313 (53.05) 
Average daily cigarettes 590 8.07 (11.17) 0-50 
Cocaine use (%) 590 21 (3.56) 
Other illicit drug use (%) 594 51 (8.64) 
Offspring Characteristics at Birth 
Gender (% male) 590 278 (47.12) 
Gestational age (weeks) 590 39.79 (2.19) 28-44 
Birth weight (kg) 590 3.20 (0.56) 1.04-4.99 
Offspring Characteristics at Age 10 
Children’s Depression Inventory T-Score 518 45.99 (8.50) 35-79 
Offspring Characteristics at Age 22 
Initiated marijuana before age 16 (%) 590 298 (50.51) 
Age (years) 590 22.83 (0.70) 21.16-26.09 
Race (% African American) 590 336 (56.95) 
Education (years) 590 12.80 (1.62) 8-18 
Employment status (% working and/ or in school) 590 360 (61.02) 
Median personal income (US$/month) 575 800 0-5000 
Lives with mother or caregiver (%) 590 208 (35.25) 
Marital status (% married) 590 33 (5.59) 
Has at least one child (%) 590 217 (36.78) 
Past-year cigarette use (%) 594 253 (42.88) 
Average daily cigarettes 590 4.27 (6.97) 0-50 
Past-year alcohol use (%) 590 545 (92.37) 
Average daily volume of alcohol 590 1.58 (2.16) 0-8 
Lifetime marijuana use (%) 590 486 (82.37) 
Past-year marijuana use (%) 590 289 (48.98) 
Average daily joints of marijuana 590 0.81 (2.06) 0-10 
Past-year cocaine use (%) 590 38 (6.44) 
Past-year use of other illicit drugs (%) 590 79 (13.39) 
125 
Cannabis Use Disorder diagnosis (%) 590 80 (13.56) 
Cannabis Use Disorder diagnosis among lifetime marijuana 
users (%) 486 80 (16.46) 
Table 21. Chapter 4: Sample characteristics by Cannabis Use Disorder diagnosis 
No CUD 
Diagnosis 
(n=510) 
CUD 
Diagnosis 
(n=80) p-valuea 
Effect 
Sizeb 
Maternal Characteristics at the First 
Trimester Visit 
Age (years) 22.99 23.29 0.546 0.073 
Race (% black) 51.76 55.00 0.590 0.022 
Education (years) 11.85 11.85 0.995 0.001 
Marital status (% married) 31.18 31.25 0.989 0.001 
Employment status (% in school and/or worked 
outside the home) 
25.69 23.75 0.712 0.015 
Household income (%<US$400/month)c 61.05 61.54 0.935 0.003 
Any alcohol use (%) 64.51 58.75 0.319 0.041 
Average daily volume of alcohol 0.53 0.68 0.968 0.133 
Any cigarette use (%) 53.53 50.00 0.556 0.024 
Average daily cigarettes 8.05 8.21 0.905 0.014 
Any marijuana use (%) 40.20 43.75 0.547 0.025 
Average daily joints 0.36 0.51 0.329 0.161 
Any cocaine use (%) 3.53 3.75 0.921 0.004 
Any other illicit drug use (%) 8.43 10.00 0.643 0.019 
Offspring Characteristics at Birth 
Gender (% male) 42.94 73.75 <0.001 0.211 
Gestational age (weeks) 39.84 39.48 0.421 0.165 
Birth weight (kg) 3.20 3.15 0.422 0.097 
Offspring Characteristics at Age 10 
Children’s Depression Inventory T-Score 
(mean)d 
45.89 46.61 0.315 0.085 
Offspring Characteristics at Age 22 
Marijuana initiation 
    Before age 16 (%) 
    Between ages 16-22 
    Never 
45.69 
33.92 
20.39 
81.25 
18.75 
0.00 
<0.001 0.256 
Age (years) 22.84 22.77 0.403 0.101 
Race (% African American) 56.86 57.50 0.915 0.004 
Education (years) 12.88 12.29 0.002 0.371 
Personal income (median US$/month)e 800.00 750.00 0.371 0.081 
Employed or in school (%) 61.57 57.50 0.488 0.029 
Marital status (% married) 5.69 5.00 0.804 0.010 
Lives with mother or caregiver (%) 35.69 32.50 0.579 0.023 
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Has at least one child (%) 36.47 38.75 0.694 0.016 
Past-year alcohol use (%) 92.55 91.25 0.684 0.017 
Average daily volume of alcohol 1.37 2.92 <0.001 0.738 
Past-year cigarette use (%) 39.22 66.25 <0.001 0.187 
Average daily cigarettes 3.81 7.21 <0.001 0.496 
Past-year marijuana use (%) 44.51 77.50 <0.001 0.226 
Average daily joints of marijuana 0.59 2.23 <0.001 0.823 
Past-year cocaine use (%) 4.90 16.25 <0.001 0.158 
Past-year other illicit drug use (%) 10.20 33.75 <0.001 0.237 
at-test for continuous variables, Mann Whitney test for skewed variables, χ2 test for 
dichotomous variables 
bCohen’s d for continuous variables, Cramer’s V for dichotomous variables; absolute value 
reported 
csample sizes: 493, 78 
dsample sizes: 446, 72 
esample sizes: 498, 77 
Table 22. Chapter 4: Fit indices for models tested during model identification 
Model χ2 df p CFI TLI RMSEA WRMR 
 1 - Conceptual model 0.056 1 0.814 1.000 1.138 0.000 0.049 
2 – Removing CUD  
Depressive Symptoms  0.161 2 0.923 1.000 1.134 0.000 0.079 
CFI=Comparative Fit Index (cut-off >.95), TLI= Tucker Lewis Index (cut-off >.90),  
RMSEA = Root Mean Square Error of Approximate (cut-off <.06), WRMR = Weighted Root 
Mean Square Residual (cut-off <.90) 
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Figure 8. Chapter 4: Conceptual path model 
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